0001493152-19-006640.txt : 20190509 0001493152-19-006640.hdr.sgml : 20190509 20190509134128 ACCESSION NUMBER: 0001493152-19-006640 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190509 DATE AS OF CHANGE: 20190509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stereotaxis, Inc. CENTRAL INDEX KEY: 0001289340 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943120386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36159 FILM NUMBER: 19809865 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 314-678-6100 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2019

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from to

 

Commission File Number: 001-36159

 

STEREOTAXIS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   94-3120386

(State of

Incorporation)

 

(I.R.S. employer

identification no.)

     

4320 Forest Park Avenue Suite 100

St. Louis, Missouri

  63108
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (314) 678-6100

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X] Yes [  ] No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Registration S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [X] Yes [  ] No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer [  ]   Accelerated filer [  ]
           
Non-accelerated filer [  ] (Do not check if a smaller reporting company)   Smaller reporting company [X]
           
        Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b -2 of the Exchange Act). [  ] Yes [X] No

 

The number of outstanding shares of the registrant’s common stock on April 30, 2019 was 59,321,209.

 

 

 

   
 

 

STEREOTAXIS, INC.

INDEX TO FORM 10-Q

 

    Page
     
Part I Financial Information  
Item 1. Financial Statements (unaudited)  
  Balance Sheets 3
  Statements of Operations 4
  Statements of Equity 5
  Statements of Cash Flows 6
  Notes to Financial Statements 7-14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 15-20
Item 3. [Reserved] 20
Item 4. Controls and Procedures 20
Part II Other Information  
Item 1. Legal Proceedings 20
Item 1A. Risk Factors 20
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20
Item 3. Defaults upon Senior Securities 20
Item 4. [Reserved] 20
Item 5. Other Information 20
Item 6. Exhibits 21
Signatures 22

 

2
 

 

ITEM 1. FINANCIAL STATEMENTS

 

STEREOTAXIS, INC.

BALANCE SHEETS

 

   March 31, 2019   December 31, 2018 
   (Unaudited)     
Assets          
Current assets:          
Cash and cash equivalents  $9,040,816   $10,796,072 
Accounts receivable, net of allowance of $458,701 and $398,847 in 2019 and 2018, respectively   5,239,470    5,021,111 
Inventories, net   1,309,134    1,191,666 
Prepaid expenses and other current assets   774,014    963,700 
Total current assets   16,363,434    17,972,549 
Property and equipment, net   328,614    343,693 
Operating lease right-of-use assets   5,580,457    - 
Other assets   170,088    198,365 
Total assets  $22,442,593   $18,514,607 
           
Liabilities and stockholders’ equity (deficit)          
Current liabilities:          
Accounts payable  $2,383,230   $1,726,360 
Accrued liabilities   2,273,687    2,642,481 
Deferred revenue   5,645,815    5,825,536 
Current portion of operating lease liabilities   2,159,944    - 
Total current liabilities   12,462,676    10,194,377 
Long-term deferred revenue   404,607    407,151 
Operating lease liabilities   3,433,430    - 
Other liabilities   813,641    641,461 
Total liabilities   17,114,354    11,242,989 
           
Convertible preferred stock:          
Convertible preferred stock, par value $0.001; 10,000,000 shares authorized, 23,880 and 23,900 shares outstanding at 2019 and 2018   5,955,354    5,960,475 
           
Stockholders’ equity (deficit):          
Common stock, par value $0.001; 300,000,000 shares authorized, 59,308,237 and 59,058,297 shares issued at 2019 and 2018, respectively   59,308    59,058 
Additional paid in capital   478,363,886    478,179,574 
Treasury stock, 4,015 shares at 2019 and 2018   (205,999)   (205,999)
Accumulated deficit   (478,844,310)   (476,721,490)
Total stockholders’ equity (deficit)   (627,115)   1,311,143 
Total liabilities and stockholders’ equity (deficit)  $22,442,593   $18,514,607 

 

See accompanying notes.

 

3
 

 

STEREOTAXIS, INC.

STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three Months Ended March 31, 
   2019   2018 
Revenue:        
Systems  $58,051   $17,275 
Disposables, service and accessories   6,710,759    6,954,357 
Sublease   241,065    - 
Total revenue   7,009,875    6,971,632 
           
Cost of revenue:          
Systems   51,163    203,602 
Disposables, service and accessories   1,114,360    1,061,745 
Sublease   246,530    - 
Total cost of revenue   1,412,053    1,265,347 
           
Gross margin   5,597,822    5,706,285 
           
Operating expenses:          
Research and development   2,959,219    1,962,626 
Sales and marketing   3,309,829    3,634,997 
General and administrative   1,468,160    1,239,179 
Total operating expenses   7,737,208    6,836,802 
Operating loss   (2,139,386)   (1,130,517)
           
Other income   -    2,590,361 
Interest income (expense)   16,566    (24,615)
Net income (loss)  $(2,122,820)  $1,435,229 
           
Cumulative dividend on convertible preferred stock   (353,510)   (353,589)
Net income attributable to convertible preferred stock   -    (610,280)
Earnings (loss) attributable to common stockholders  $(2,476,330)  $471,360 
           
Net income (loss) per share attributable to common stockholders:          
Basic  $(0.04)  $0.02 
Diluted  $(0.04)  $0.01 
           
Weighted average number of common shares and equivalents:          
Basic   59,196,652    30,957,648 
Diluted   59,196,652    33,122,598 

 

See accompanying notes.

 

4
 

 

STEREOTAXIS, INC

STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY

(Unaudited)

 

   Three Months Ended March 31, 2018           Total 
   Convertible           Additional           Stockholders’ 
   Preferred Stock   Common Stock   Paid-In   Treasury   Accumulated   Equity 
   Shares   Amount   Shares   Amount   Capital   Stock   Deficit   (Deficit) 
Balance at December 31, 2017   23,900   $5,960,475    22,805,731   $22,806   $450,748,403   $(205,999)  $(477,132,808)  $(26,567,598)
Issuance of common stock and warrants             35,791,927    35,792    26,893,991              26,929,783 
Share-based compensation             285,662    286    216,388              216,674 
Components of net income                                 1,435,228    1,435,228 
Employee stock purchase plan             17,806    17    13,514              13,531 
Cumulative catchup for adoption of ASC 606 (1)                                 294,562    294,562 
Balance at March 31, 2018   23,900   $5,960,475    58,901,126   $58,901   $477,872,296   $(205,999)  $(475,403,018)  $2,322,180 

 

   Three Months Ended March 31, 2019           Total 
   Convertible           Additional           Stockholders’ 
   Preferred Stock   Common Stock   Paid-In   Treasury   Accumulated   Equity 
   Shares   Amount   Shares   Amount   Capital   Stock   Deficit   (Deficit) 
                                 
Balance at December 31, 2018   23,900   $5,960,475    59,058,297   $59,058   $478,179,574   $(205,999)  $(476,721,490)  $1,311,143 
Issuance of common stock and warrants             33,087    33    16,390              16,423 
Share-based compensation             166,962    167    147,787              147,954 
Components of net loss                                 (2,122,820)   (2,122,820)
Employee stock purchase plan             14,625    15    15,049              15,064 
Preferred stock conversion   (20)   (5,121)   35,266    35    5,086              5,121 
Balance at March 31, 2019   23,880   $5,955,354    59,308,237   $59,308   $478,363,886   $(205,999)  $(478,844,310)  $(627,115)

 

(1) Represents the adjustments related to the adoption of new accounting standards. See Note 2 for details.

 

See accompanying notes.

 

5
 

 

STEREOTAXIS, INC.

STATEMENTS OF CASH FLOWS

(Unaudited)

 

   Three Months Ended March 31, 
   2019   2018 
Cash flows from operating activities          
Net income (loss)  $(2,122,820)  $1,435,229 
Adjustments to reconcile net income (loss) to cash used in operating activities:          
Depreciation   24,912    140,465 
Amortization of intangibles   -    16,497 
Amortization of deferred finance costs   -    24,657 
Amortization of right-of-use asset   567,857    - 
Share-based compensation   147,923    216,586 
Adjustment of warrants   -    (2,590,361)
Changes in operating assets and liabilities:          
Accounts receivable   (218,359)   (2,350,333)
Inventories   (117,468)   (299,603)
Prepaid expenses and other current assets   189,686    97,206 
Other assets   41,194    (57,059)
Accounts payable   656,870    165,322 
Accrued liabilities   (368,794)   (247,570)
Deferred revenue   (182,265)   1,382,082 
Operating lease liability   (567,857)   - 
Other liabilities   172,180    45,497 
Net cash used in operating activities   (1,776,941)   (2,021,385)
Cash flows from investing activities          
Purchase of fixed assets   (9,833)   (9,990)
Net cash used in investing activities   (9,833)   (9,990)
Cash flows from financing activities          
Proceeds from issuance of stock, net of issuance costs   31,518    13,622 
Proceeds from warrant exercise   -    9,945,164 
Net cash provided by financing activities   31,518    9,958,786 
Net increase (decrease) in cash and cash equivalents   (1,755,256)   7,927,411 
Cash and cash equivalents at beginning of period   10,796,072    3,686,302 
Cash and cash equivalents at end of period  $9,040,816   $11,613,713 

 

See accompanying notes.

 

6
 

 

STEREOTAXIS, INC.

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

 

Notes to Financial Statements

 

In this report, “Stereotaxis”, the “Company”, “Registrant”, “we”, “us”, and “our” refer to Stereotaxis, Inc. and its wholly owned subsidiaries. Genesis™, Epoch®, Niobe®, Odyssey®, Odyssey Cinema™, Vdrive®, Vdrive Duo™, V-CAS™, V-Loop™, V-Sono™, V-CAS Deflect™, QuikCAS™, and Cardiodrive® are trademarks of Stereotaxis, Inc. All other trademarks that appear in this report are the property of their respective owners.

 

1. Description of Business

 

Stereotaxis designs, manufactures and markets an advanced remote robotic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our products include the Genesis Robotic Magnetic Navigation System (“Genesis system”), the Niobe ES Robotic Magnetic Navigation System (“Niobe ES system”), Odyssey Information Management Solution (“Odyssey Solution”), the Vdrive Robotic Navigation System (“Vdrive system”), Stereotaxis Imaging Model S x-ray system, and related devices.

 

The Genesis and Niobe systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures, and reduced x-ray exposure. As of March 31, 2019, the Company had an installed base of 126 Niobe ES systems.

 

In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the Odyssey Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution delivering synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and training.

 

Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the robotic magnetic navigation systems’ control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the Vdrive system and the Vdrive Duo system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components which can be manipulated by these systems.

 

We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.

 

The Niobe System, Odyssey Workstation, Cardiodrive, and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and Europe. The Genesis system and the V-CAS Deflect catheter advancement system have been CE Marked for sale in the Europe. Stereotaxis Imaging Model S is CE marked and FDA cleared.

 

We have strategic relationships with technology leaders in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices, in order to continue to develop new solutions in the interventional lab. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. The commercial availability of currently compatible digital imaging fluoroscopy systems is unlikely to continue and efforts are being made to ensure the availability of integrated next generation systems and/or equivalent alternatives; however, we cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.

 

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.

 

7
 

 

Going Concern, Liquidity and Management’s Plan

 

The Company believes the cash on hand at March 31, 2019 will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. The Company has sustained operating losses throughout its corporate history and expects that its 2019 expenses will exceed its 2019 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of robotic magnetic navigation systems as well as by new placements of capital systems. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.

 

Financial Instruments

 

Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).

 

Revenue and Costs of Revenue

 

The Company adopted Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from Contracts with Customers, on January 1, 2018.

 

We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented less than 1% of revenue for the three months ended March 31, 2019 and 2018.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 36% and 37% of revenue for the three months ended March 31, 2019 and 2018, respectively.

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 11% and 10% of revenue for the three months ended March 31, 2019 and 2018.

 

8
 

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 50% and 53% of revenue for the three months ended March 31, 2019 and 2018, respectively.

 

Sublease Revenue:

 

The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning with three months ended March 31, 2019. Sublease revenue represented 3% and 0% of revenue for the three months ended March 31, 2019 and 2018, respectively.

 

   Three Months Ended March 31, 
   2019   2018 
Systems  $58,051   $17,275 
Disposables, service and accessories   6,710,759    6,954,357 
Sublease   241,065     
Total revenue  $7,009,875   $6,971,632 

 

Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $2.7 million as of March 31, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.

 

The following information summarizes the Company’s contract assets and liabilities:

 

   March 31, 2019   December 31, 2018 
Contract Assets - Unbilled Receivables  $268,711   $251,867 
           
Customer deposits   428,595    487,086 
Product shipped, revenue deferred   645,199    645,199 
Deferred service and license fees   4,976,628    5,100,402 
Total deferred revenue   6,050,422    6,232,687 
Less: Long-term deferred revenue   (404,607)   (407,151)
Total current deferred revenue  $5,645,815   $5,825,536 

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Revenue recognized for the three months ended March 31, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $2.9 million and $2.7 million respectively.

 

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $0.3 million as of March 31, 2019. The Company did not incur any impairment losses during any of the periods presented.

 

9
 

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

 

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

 

Net Income (Loss) per Common Share (“EPS”)

 

Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

 

The following table sets forth the computation of basic and diluted EPS:

 

   Three months ended March 31, 
   2019   2018 
Net income (loss)  $(2,122,820)  $1,435,229 
Cumulative dividend on convertible preferred stock   (353,510)   (353,589)
Net loss attributable to convertible preferred stock       (610,280)
Net income (loss) attributable to common stockholders  $(2,476,330)  $471,360 
           
Share used for basic EPS-weighted average shares   59,196,652    30,957,648 
Restricted Stock Units       292,891 
Warrants       1,872,059 
Weighted average number of common shares and equivalents:   59,196,652    33,122,598 
Basic EPS  $(0.04)  $0.02 
Diluted EPS  $(0.04)  $0.01 

 

The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common share for the three months ended March 31, 2019 because all such securities are anti-dilutive. The following potential common shares were excluded from diluted EPS for the three months ended March 31, 2018 as they were antidilutive: 1,236,445 stock options and stock appreciation rights, 280,560 restricted stock units, and 1,077,255 warrants. The Company had no unearned restricted shares during either period.

 

As of March 31, 2019, the Company had 2,131,513 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.32 per share, 1,107,689 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 42,252,248 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock and accumulated dividends, and 688,687 shares of unvested restricted share units.

 

Recently Issued Accounting Pronouncements

 

Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (“ASC 842”) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity’s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease Revenue and the related cost as Sublease Cost of Goods Sold. See Note 6 for additional details.

 

10
 

 

3. Inventories

 

Inventories consist of the following:

 

   March 31, 2019   December 31, 2018 
         
Raw materials  $2,657,958   $2,686,870 
Work in process   133,218    2,594 
Finished goods   2,944,522    2,963,013 
Reserve for obsolescence   (4,426,564)   (4,460,811)
Total inventory  $1,309,134   $1,191,666 

 

4. Prepaid Expenses and Other Assets

 

Prepaid expenses and other assets consist of the following:

 

   March 31, 2019   December 31, 2018 
         
Prepaid expenses  $434,560   $401,972 
Prepaid commissions   271,664    304,585 
Deposits   237,878    455,508 
Total prepaid expenses and other assets   944,102    1,162,065 
Less: Noncurrent prepaid expenses and other assets   (170,088)   (198,365)
Total current prepaid expenses and other assets  $774,014   $963,700 

 

5. Property and Equipment

 

Property and equipment consist of the following:

 

   March 31, 2019   December 31, 2018 
         
Equipment  $6,841,498   $6,831,665 
Leasehold improvements   2,592,339    2,592,339 
    9,433,837    9,424,004 
Less: Accumulated depreciation   (9,105,223)   (9,080,311)
Net property and equipment  $328,614   $343,693 

 

6. Leases

 

A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842. The Company determines if an arrangement contains a lease at inception. For the Company, Accounting Standards Codification (“ASC 842”) primarily affected the accounting treatment for operating lease agreements in which the Company is the lessee.

 

The Company leases its facilities under operating leases, which were previously not recognized on the Company’s balance sheets. With the adoption of ASC 842, operating lease agreements are required to be recognized on the balance sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases do not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. A portion of our principal executive office is subleased to a third party through 2021. The sublease does not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. In addition, the sublease does not contain contingent rent provisions nor are there options to extend or terminate the sublease.

 

11
 

 

The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e., leases with initial terms of twelve months or less) on the balance sheet.

 

The calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception. At March 31, 2019, the weighted average discount rate for operating leases was 9.0% and the weighted average remaining lease term for operating lease term is 2.75 years.

 

The following table represents lease costs and other lease information.

 

   Three Months Ended 
   March 31, 2019 
     
Operating lease cost  $585,586 
Short-term lease cost   19,809 
Sublease income   (241,065)
Total lease cost  $364,330 
      
Cash paid within operating cash flows  $615,266 

 

The initial recognition of the right of use assets was $6.2 million. Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment which are paid based on actual costs incurred.

 

Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2019, excluding sublease income, were as follows:

 

   March 31, 2019 
     
2019  $1,717,837 
2020   2,339,810 
2021   2,382,661 
2022 and thereafter   - 
Total lease payments  $6,440,308 
Less: Interest   (846,934)
Present value of lease liabilities  $5,593,374 

 

The undiscounted future cash flows to be received under the sublease are $0.7 million in 2019, $1.0 million in 2020 and $1.0 million in 2021.

 

7. Accrued Liabilities

 

Accrued liabilities consist of the following:

 

   March 31, 2019   December 31, 2018 
         
Accrued salaries, bonus, and benefits  $1,182,958   $1,491,844 
Accrued licenses and maintenance fees   483,879    576,598 
Accrued warranties   136,946    149,464 
Accrued taxes   188,074    251,988 
Accrued professional services   765,948    430,088 
Other   329,523    383,960 
Total accrued liabilities   3,087,328    3,283,942 
Less: Long term accrued liabilities   (813,641)   (641,461)
Total current accrued liabilities  $2,273,687   $2,642,481 

 

12
 

 

8. Long-Term Debt and Credit Facilities

 

The Company had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The working capital line of credit matured on April 25, 2019. The revolving line of credit was secured by substantially all of the Company’s assets. The maximum available under the line was $5.0 million subject to the value of collateralized assets and the interest rate was equal to the prime rate subject to a floor of 4.5%. The Company was required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender.

 

As of March 31, 2019, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit were made based on the borrowing capacity one week in arrears. As of March 31, 2019, the Company had a borrowing capacity of $3.3 million based on the Company’s collateralized assets. The Company’s total liquidity as of March 31, 2019, was $12.3 million which included cash and cash equivalents of $9.0 million.

 

9. Convertible Preferred Stock and Stockholders’ Equity

 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of March 31, 2019.

 

Convertible Preferred Stock and Warrants

 

In September 2016, the Company issued 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company’s common stock at an initial conversion rate of $0.65 per share and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Each holder of convertible preferred shares has the right to require us to redeem such holder’s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a defined change of control. The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company’s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.

 

The warrants issued in conjunction with the convertible preferred stock (the “SPA Warrants”) have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants were originally puttable upon the occurrence of certain events outside of the Company’s control, and were classified as liabilities under Accounting Standards Codification (“ASC”) Topic 480-10. The calculated fair value of the warrants was periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations.

 

The warrants were modified on February 28, 2018 to allow for a reduction in the exercise price from $0.70 per share to $0.28 per share for a period between March 1, 2018 and March 5, 2018. Any holder who exercised warrants at the reduced strike price was required to enter into a lock-up agreement with the Company agreeing not to sell the warrants or the common shares received upon exercise of the warrants for a period of 18 months following March 12, 2018. Additionally, the beneficial ownership limitation related to the warrants was modified and the right of holders to require the Company to redeem their SPA Warrants in exchange for cash in certain circumstances was eliminated. Following these modifications, the warrants were no longer subject to liability accounting and were reclassified to equity. During the restricted exercise period, Stereotaxis received exercise notices for 35,791,927 warrants and received an aggregate of $10.0 million in cash from the warrant exercise. As a result of these transactions, total stockholders’ equity increased by $27 million and common shares outstanding increased by 35,791,927 shares. The Consent and Amendment and the Amended and Restated Form of Warrants are available in a Form 8-K filed with the Securities and Exchange Commission on March 6, 2018.

 

Stock Award Plans

 

The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.

 

13
 

 

On June 5, 2013, June 10, 2014, May 24, 2016, and May 23, 2017, the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares, and the amendment on May 23, 2017 increased the number of shares authorized for issuance under the Plan by 4.0 million shares. At March 31, 2019, the Company had 3,246,524 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

 

At March 31, 2019, the total compensation cost related to options, stock appreciation rights, and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $2.2 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.

 

A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2019 is as follows:

 

   Number of Options/SARs   Range of Exercise Price   Weighted Average Exercise Price per Share 
             
Outstanding, December 31, 2018   1,165,086    $0.74 - $43.90   $2.54 
Granted   982,000   $2.03   $2.03 
Exercised   (9,625)   $0.74 - $0.83   $0.74 
Forfeited   (5,948)   $0.74 - $4.04   $1.59 
Outstanding, March 31, 2019   2,131,513    $0.74 - $43.90   $2.32 

 

A summary of the restricted stock unit activity for the three month period ended March 31, 2019 is as follows:

 

   Number of Restricted
Stock Units
   Weighted Average Grant Date Fair Value per Unit 
         
Outstanding, December 31, 2018   647,649   $0.83 
Granted   210,000   $1.19 
Vested   (166,962)  $1.12 
Forfeited   (2,000)  $0.72 
Outstanding, March 31, 2019   688,687   $0.87 

 

10. Product Warranty Provisions

 

The Company’s standard policy is to warrant all capital systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

 

Accrued warranty, which is included in other accrued liabilities, consists of the following:

 

   March 31, 2019   December 31, 2018 
Warranty accrual, beginning of the fiscal period  $149,464   $164,365 
Accrual adjustment for product warranty   17,135    34,253 
Payments made   (29,653)   (49,154)
Warranty accrual, end of the fiscal period  $136,946   $149,464 

 

11. Commitments and Contingencies

 

The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

 

12. Subsequent Events

 

None.

 

14
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our financial statements and notes thereto included in this report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2018. Operating results are not necessarily indicative of results that may occur in future periods.

 

This report includes various forward-looking statements that are subject to risks and uncertainties, many of which are beyond our control. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in “Item 1A. Risk Factors.” Forward-looking statements discuss matters that are not historical facts. Forward-looking statements include, but are not limited to, discussions regarding our operating strategy, sales and marketing strategy, regulatory strategy, industry, economic conditions, financial condition, liquidity, capital resources, and results of operations. Such statements include, but are not limited to, statements preceded by, followed by, or that otherwise include the words “believe”, “expects”, “anticipates”, “intends”, “estimates”, “projects”, “can”, “could”, “may”, “would”, or similar expressions. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. You should not unduly rely on these forward-looking statements, which speak only as of the date on which they are made. They give our expectations regarding the future, but are not guarantees. We undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

 

Overview

 

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital’s interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Our capital products include the Genesis system, the Niobe system, Odyssey Solution, the Vdrive system, and the Stereotaxis Imaging Model S x-ray system. We believe that the robotic magnetic navigation systems represent a revolutionary technology in the interventional surgical suite, or “interventional lab,” and have the potential to become the standard of care for a broad range of complex cardiology procedures. We also believe that our technology represents an important advance in the ongoing trend toward digital instrumentation in the interventional lab and provides substantial, clinically important improvements, and cost efficiencies over manual interventional methods, which require years of physician training and often result in long and unpredictable procedure times and sub-optimal therapeutic outcomes.

 

The Genesis system is the latest generation of the robotic magnetic navigation system. This system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures and reduced x-ray exposure. The Genesis system is CE marked and will become available in other global geographies subject to regulatory approval. The core components of the Niobe system have received regulatory clearance in the U.S., Canada, Europe, China, Japan, and various other countries. As of March 31, 2019, the Company had an installed base of 126 Niobe ES systems.

 

Stereotaxis also has developed the Odyssey Solution which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution delivering synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and training. The Odyssey Solution may be acquired in conjunction with a robotic magnetic navigation system or on a stand-alone basis for installation in interventional labs and other locations where clinicians often desire the benefits of the Odyssey Solution that we believe can improve clinical workflows and related efficiencies.

 

Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the robotic magnetic navigation system’s control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the Vdrive system and the Vdrive Duo system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components (V-Loop, V-Sono, V-CAS, and V-CAS Deflect) which can be manipulated by these systems.

 

We have strategic relationships with technology leaders in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices, in order to continue to develop new solutions in the interventional lab. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. The commercial availability of currently compatible digital imaging fluoroscopy systems is unlikely to continue and efforts are being made to ensure the availability of integrated next generation systems and/or equivalent alternatives; however, we cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

 

15
 

 

Going Concern, Liquidity and Management’s Plan

 

The Company believes the cash on hand at March 31, 2019 will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. The Company has sustained operating losses throughout its corporate history and expects that its 2019 expenses will exceed its 2019 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of Niobe systems as well as by new placements of capital systems. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. We review our estimates and judgments on an on-going basis. We base our estimates and judgments on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. We believe the following accounting policies are critical to the judgments and estimates we use in preparing our financial statements. For a complete listing of our critical accounting policies, please refer to our Annual Report on Form 10-K for the year ended December 31, 2018.

 

Revenue Recognition

 

The Company adopted Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from Contracts with Customers, on January 1, 2018. We generate revenue from the initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year warranty; warranty costs were not material for the periods presented.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by a warranty that provides for the return of defective products. Warranty costs were not material for the periods presented.

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed.

 

16
 

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. See Note 2 for additional detail on Deferred Revenue. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets in the Company’s balance sheets were $0.3 million as of March 31, 2019. The Company did not incur any impairment losses during any of the periods presented.

 

Leases

 

On January 1, 2019, the Company adopted ASU No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842. A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The Company determines if a contract contains a lease at inception. For contracts where the Company is the lessee, operating leases are included in operating lease right-of-use (ROU) assets and operating lease liability on the Company’s balance sheet. The Company currently does not have any finance leases.

 

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as the Company’s leases generally do not provide an implicit rate. Lease terms may include options to extend or terminate when the Company is reasonably certain that the option will be exercised. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company’s operating leases. Additionally, the Company applies the short-term lease measurement and recognition exemption in which right of use assets and lease liabilities are not recognized for leases less than twelve months.

 

Cost of Contracts

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

 

Results of Operations

 

Comparison of the Three Months Ended March 31, 2019 and 2018

 

Revenue. Revenue remained consistent at $7.0 million for the three months ended March 31, 2018 and March 31, 2019. Revenue from the sale of systems remained relatively consistent at less than $0.1 million. Revenue from sales of disposable interventional devices, service, and accessories decreased to $6.7 million for the three months ended March 31, 2019 from $7.0 million for the three months ended March 31, 2018, a decrease of approximately 4% due to decreased service revenue. The adoption of new lease accounting guidance as of January 1, 2019 required the Company to record $0.2 million of sublease income as revenue for the three months ended March 31, 2019.

 

Cost of Revenue. Cost of revenue increased from $1.3 million for the three months ended March 31, 2018 to $1.4 million for the three months ended March 31, 2019, an increase of approximately 12%. As a percentage of our total revenue, overall gross margin decreased to 80% for the three months ended March 31, 2019 from 82% for the three months ended March 31, 2018. Excluding the impact of the new lease guidance, cost of revenue for the three months ended March 31, 2019 was 83%. Cost of revenue for systems sold decreased from $0.2 million for the three months ended March 31, 2018 to $0.1 million for the three months ended March 31, 2019. Gross margin for systems increased to less than $0.1 million for the three months ended March 31, 2019 from negative $0.2 million for the three months ended March 31, 2018 primarily due to lower costs. Cost of revenue for disposables, service, and accessories remained relatively consistent at $1.1 million for the three months ended March 31, 2019 and March 31, 2018. Gross margin for disposables, service, and accessories was 83% for the current quarter compared to 85% for the three months ended March 31, 2018. The adoption of new lease accounting guidance as of January 1, 2019 required the Company to record $0.2 million of cost of sublease for the three months ended March 31, 2019.

 

17
 

 

Research and Development Expenses. Research and development expenses increased from $2.0 million for the three months ended March 31, 2018 to $3.0 million for the three months ended March 31, 2019, an increase of approximately 51%. This increase was primarily due to spending for new projects.

 

Sales and Marketing Expenses. Sales and marketing expenses decreased from $3.6 million for the three months ended March 31, 2018 to $3.3 million for the three months ended March 31, 2019, a decrease of approximately 9%. This decrease was primarily due to lower headcount and outsourced costs resulting from continued improvements in the distribution of clinical sales resources.

 

General and Administrative Expenses. General and administrative expenses include finance, information systems, legal, and general management. General and administrative expenses increased from $1.2 million for the three months ended March 31, 2018 to $1.5 million for the three months ended March 31, 2019, an increase of approximately 18%. This increase was primarily due to increased consulting costs.

 

Other Income (Expense). Other income (expense) represents the non-cash change in market value of certain warrants classified as a derivative and recorded as a current liability under general accounting principles for determining whether an instrument (or embedded feature) is indexed to an entity’s own stock.

 

Interest Income (Expense). Interest income for the three months ended March 31, 2019 was less than $0.1 million compared to interest expense of less than $0.1 million for the three months ended March 31, 2018.

 

Liquidity and Capital Resources

 

Liquidity refers to the liquid financial assets available to fund our business operations and pay for near-term obligations. These liquid financial assets consist of cash and cash equivalents. At March 31, 2019 we had $9.0 million of cash and equivalents. We had working capital of $3.9 million as of March 31, 2019 compared to approximately $7.8 million as of December 31, 2018. The decrease in working capital was primarily driven by net loss incurred during the first quarter of 2019 as well as the adoption of the new lease accounting guidance.

 

The following table summarizes our cash flow by operating, investing and financing activities for the three months ended March 31, 2019 and 2018 (in thousands):

 

   Three Months Ended March 31, 
   2019   2018 
Cash flow used in operating activities  $(1,777)  $(2,021)
Cash flow used in investing activities   (10)   (10)
Cash flow (used in)/provided by financing activities   32    9,959 

 

Net cash used in operating activities. We used approximately $1.8 million and $2.0 million of cash for operating activities during the three months ended March 31, 2019 and 2018, respectively. The decrease in cash used in operating activities was driven by improved working capital partially offset by larger operating losses.

 

Net cash used in investing activities. We used approximately $10,000 of cash in each of the three month periods ended March 31, 2019 and March 31, 2018 for purchases of equipment.

 

Net cash provided by financing activities. We generated less than $0.1 million of cash for the three month period ended March 31, 2019, compared to approximately $10.0 million generated for the three month period ended March 31, 2018. The cash generated for the three month period ended March 31, 2019 was driven by the proceeds from issuance of stock, net of issuance costs. The cash generated for the three months ended March 31, 2018 was primarily driven by the warrant exercise in March 2018.

 

The Company believes the cash on hand at March 31, 2019 will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. The Company has sustained operating losses throughout its corporate history and expects that its 2019 expenses will exceed its 2019 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of robotic magnetic navigation systems as well as by new placements of capital systems. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.

 

Until we can generate significant cash flow from our operations, we expect to continue to fund our operations with cash resources primarily generated from the proceeds of our past and future public offerings, private sales of our equity securities and working capital, and equipment financing loans. In the future, we may finance cash needs through the sale of other equity securities or non-core assets, strategic collaboration agreements, debt financings, or through distribution rights. We cannot assure you that such additional financing will be available on a timely basis on terms acceptable to us or at all, that we will be able to engage in equity financings because our common stock is no longer listed on a national securities exchange, or that such financing will not be dilutive to our stockholders. If adequate funds are not available to us, we could be required to delay development or commercialization of new products, to license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize ourselves or to reduce the sales, marketing, customer support, or other resources devoted to our products, any of which could have a material adverse effect on our business, financial condition, and results of operations. In addition, we could be required to cease operations.

 

18
 

 

Capital Resources

 

As of March 31, 2019, our borrowing facilities were comprised of a revolving line of credit maintained with our primary lender, Silicon Valley Bank.

 

Revolving Line of Credit

 

The Company had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The working capital line of credit matured on April 25, 2019. The revolving line of credit was secured by substantially all of the Company’s assets. The maximum available under the line was $5.0 million subject to the value of collateralized assets and the interest rate was equal to the prime rate subject to a floor of 4.5%. The Company was required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender.

 

As of March 31, 2019, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit were made based on the borrowing capacity one week in arrears. As of March 31, 2019, the Company had a borrowing capacity of $3.3 million based on the Company’s collateralized assets. The Company’s total liquidity as of March 31, 2019, was $12.3 million which included cash and cash equivalents of $9.0 million.

 

Common Stock

 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of March 31, 2019.

 

Convertible Preferred Stock and Warrants

 

In September 2016, the Company issued 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company’s common stock at an initial conversion rate of $0.65 per share and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Each holder of convertible preferred shares has the right to require us to redeem such holder’s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a defined change of control. The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company’s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.

 

The warrants issued in conjunction with the convertible preferred stock (the “SPA Warrants”) have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants were originally puttable upon the occurrence of certain events outside of the Company’s control, and were classified as liabilities under Accounting Standards Codification (“ASC”) Topic 480-10. The calculated fair value of the warrants was periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations.

 

The warrants were modified on February 28, 2018 to allow for a reduction in the exercise price from $0.70 per share to $0.28 per share for a period between March 1, 2018 and March 5, 2018. Any holder who exercised warrants at the reduced strike price was required to enter into a lock-up agreement with the Company agreeing not to sell the warrants or the common shares received upon exercise of the warrants for a period of 18 months following March 12, 2018. Additionally, the beneficial ownership limitation related to the warrants was modified and the right of holders to require the Company to redeem their SPA Warrants in exchange for cash in certain circumstances was eliminated. Following these modifications, the warrants were no longer subject to liability accounting and were reclassified to equity. During the restricted exercise period, Stereotaxis received exercise notices for 35,791,927 warrants and received an aggregate of $10.0 million in cash from the warrant exercise. As a result of these transactions, total stockholders’ equity increased by $27 million and common shares outstanding increased by 35,791,927 shares. The Consent and Amendment and the Amended and Restated Form of Warrants are available in a Form 8-K filed with the Securities and Exchange Commission on March 6, 2018.

 

19
 

 

Off-Balance Sheet Arrangements

 

We do not currently have, nor have we ever had, any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts. As a result, we are not materially exposed to any financing, liquidity, market, or credit risk that could have arisen if we had engaged in these relationships.

 

ITEM 3. [RESERVED]

 

None.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.

 

Changes In Internal Control Over Financial Reporting: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, also conducted an evaluation of the Company’s internal control over financial reporting to determine whether any changes occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. Based on that evaluation, there has been no such change during the period covered by this report.

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We are involved from time to time in various lawsuits and claims arising in the normal course of business. Although the outcomes of these lawsuits and claims are uncertain, we do not believe any of them will have a material adverse effect on our business, financial condition or results of operations.

 

ITEM 1A. RISK FACTORS

 

Additional Risk Factors are discussed in our Annual Report on Form 10-K for the year ended December 31, 2018.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. [RESERVED]

 

None.

 

ITEM 5. OTHER INFORMATION

 

None.

 

20
 

 

ITEM 6. EXHIBITS

 

Number   Description
     
3.1   Restated Articles of Incorporation of the Registrant, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004.
     
3.2  

Certificate of Amendment to Amended and Restated Certificate of Incorporation, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K (File No. 000-50884) filed on July 10, 2012.

     
3.3   Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock, incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 001-36159) filed on September 30, 2016.
     
3.4   Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.2 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004.
     
31.1   Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).
     
31.2   Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).
     
32.1   Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).
     
32.2   Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).
     
101.INS   XBRL Instance Document.
     
101.SCH   XBRL Taxonomy Extension Schema Document.
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document.

 

21
 

 

STEREOTAXIS, INC.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  STEREOTAXIS, INC.
  (Registrant)
     
Date: May 9, 2019 By: /s/ David L. Fischel
    David L. Fischel
    Chief Executive Officer

 

Date: May 9, 2019 By: /s/ Martin C. Stammer
    Martin C. Stammer
    Chief Financial Officer

 

22
 

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

Certification of Principal Executive Officer

 

I, David L. Fischel, certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
     
  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 9, 2019 /s/ David L. Fischel
  David L. Fischel
  Chief Executive Officer
  Stereotaxis, Inc.
  (Principal Executive Officer)

 

 

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

Certification of Principal Financial Officer

 

I, Martin C. Stammer, certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
     
  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 9, 2019 /s/ Martin C. Stammer
  Martin C. Stammer
  Chief Financial Officer
  Stereotaxis, Inc.
  (Principal Financial Officer)

 

 

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David L. Fischel, Chief Executive Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 9, 2019 /s/ David L. Fischel
  David L. Fischel
  Chief Executive Officer
  Stereotaxis, Inc.

 

 

 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Martin C. Stammer, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 9, 2019 /s/ Martin C. Stammer
  Martin C. Stammer
  Chief Financial Officer
  Stereotaxis, Inc.

 

 

 

 

EX-101.INS 6 stxs-20190331.xml XBRL INSTANCE FILE 0001289340 2019-01-01 2019-03-31 0001289340 2019-03-31 0001289340 2017-12-31 0001289340 STXS:SystemsMember 2019-01-01 2019-03-31 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2019-01-01 2019-03-31 0001289340 STXS:SystemsMember 2018-01-01 2018-03-31 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2018-01-01 2018-03-31 0001289340 STXS:ContractAssetsUnbilledReceivablesMember 2019-03-31 0001289340 STXS:ContractAssetsUnbilledReceivablesMember 2018-12-31 0001289340 STXS:ProductShippedRevenueDeferredMember 2019-03-31 0001289340 STXS:ProductShippedRevenueDeferredMember 2018-12-31 0001289340 STXS:DeferredServiceAndLicenseFeesMember 2019-03-31 0001289340 STXS:DeferredServiceAndLicenseFeesMember 2018-12-31 0001289340 us-gaap:EquipmentMember 2019-03-31 0001289340 us-gaap:EquipmentMember 2018-12-31 0001289340 us-gaap:LeaseholdImprovementsMember 2019-03-31 0001289340 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001289340 us-gaap:RevolvingCreditFacilityMember 2019-03-31 0001289340 STXS:RangeOneMember 2019-01-01 2019-03-31 0001289340 STXS:RangeTwoMember 2019-01-01 2019-03-31 0001289340 STXS:RangeThreeMember 2019-01-01 2019-03-31 0001289340 STXS:RangeFourMember 2019-01-01 2019-03-31 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2014-06-09 2014-06-10 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001289340 srt:MinimumMember 2018-03-05 0001289340 srt:MaximumMember 2018-03-05 0001289340 2019-04-30 0001289340 STXS:RangeFiveMember 2019-01-01 2019-03-31 0001289340 us-gaap:CommonStockMember 2017-12-31 0001289340 us-gaap:CommonStockMember 2018-12-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001289340 us-gaap:TreasuryStockMember 2017-12-31 0001289340 us-gaap:TreasuryStockMember 2018-12-31 0001289340 us-gaap:RetainedEarningsMember 2017-12-31 0001289340 us-gaap:RetainedEarningsMember 2018-12-31 0001289340 us-gaap:ConvertiblePreferredStockMember 2017-12-31 0001289340 us-gaap:ConvertiblePreferredStockMember 2018-12-31 0001289340 STXS:CustomerDepositsMember 2019-03-31 0001289340 STXS:CustomerDepositsMember 2018-12-31 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2016-09-01 2016-09-30 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2016-09-30 0001289340 us-gaap:WarrantMember 2018-03-01 2018-03-05 0001289340 2018-12-31 0001289340 2018-01-01 2018-03-31 0001289340 us-gaap:ConvertiblePreferredStockMember 2018-01-01 2018-03-31 0001289340 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-03-31 0001289340 us-gaap:ConvertiblePreferredStockMember 2018-03-31 0001289340 us-gaap:ConvertiblePreferredStockMember 2019-03-31 0001289340 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001289340 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001289340 us-gaap:CommonStockMember 2018-03-31 0001289340 us-gaap:CommonStockMember 2019-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001289340 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0001289340 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0001289340 us-gaap:TreasuryStockMember 2018-03-31 0001289340 us-gaap:TreasuryStockMember 2019-03-31 0001289340 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001289340 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001289340 us-gaap:RetainedEarningsMember 2018-03-31 0001289340 us-gaap:RetainedEarningsMember 2019-03-31 0001289340 2018-03-31 0001289340 STXS:RevenueFromSystemDeliveryAndInstallationMember 2019-01-01 2019-03-31 0001289340 STXS:RevenueFromSystemDeliveryAndInstallationMember 2018-01-01 2018-03-31 0001289340 STXS:DisposableRevenueMember 2019-01-01 2019-03-31 0001289340 STXS:DisposableRevenueMember 2018-01-01 2018-03-31 0001289340 STXS:RoyaltyRevenueMember 2019-01-01 2019-03-31 0001289340 STXS:RoyaltyRevenueMember 2018-01-01 2018-03-31 0001289340 STXS:OtherRecurringRevenueMember 2019-01-01 2019-03-31 0001289340 STXS:OtherRecurringRevenueMember 2018-01-01 2018-03-31 0001289340 STXS:SubleaseRevenueMember 2019-01-01 2019-03-31 0001289340 STXS:SubleaseRevenueMember 2018-01-01 2018-03-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2013-06-03 2013-06-05 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2016-05-22 2016-05-24 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2017-05-21 2017-05-23 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2019-03-31 0001289340 2018-01-01 2018-12-31 0001289340 STXS:StockOptionsandStockAppreciationRightsMember 2018-01-01 2018-03-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0001289340 us-gaap:WarrantMember 2018-01-01 2018-03-31 0001289340 STXS:StockOptionsandStockAppreciationRightsMember 2019-03-31 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2019-03-31 0001289340 us-gaap:WarrantMember 2019-03-31 0001289340 us-gaap:RevolvingCreditFacilityMember STXS:PrimaryLenderMember 2019-03-31 0001289340 us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember STXS:PrimaryLenderMember 2019-01-01 2019-03-31 0001289340 2018-03-01 2018-03-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure STXS:Integer Stereotaxis, Inc. 0001289340 10-Q 2019-03-31 false --12-31 Non-accelerated Filer Q1 2019 458701 398847 0.001 1000 0.001 10000000 10000000 23880 23900 0.001 0.001 300000000 300000000 59308237 59058297 4015 4015 5239470 5021111 9040816 10796072 1309134 1191666 774014 963700 16363434 17972549 328614 343693 170088 198365 22442593 18514607 2273687 2642481 2383230 1726360 5955354 5960475 59308 59058 22442593 18514607 -627115 -26567598 22806 59058 450748403 478179574 -205999 -205999 -477132808 -476721490 5960475 5960475 1311143 5960475 5955354 58901 59308 477872296 478363886 -205999 -205999 -475403018 -478844310 2322180 -478844310 -476721490 205999 205999 478363886 478179574 12462676 10194377 813641 641461 17114354 11242989 1412053 51163 1114360 203602 1061745 1265347 5597822 5706285 -2139386 -1130517 7737208 6836802 1468160 1239179 3309829 3634997 2959219 1962626 -2122820 1435229 1435228 -2122820 -16566 24615 -2476330 471360 -0.04 0.01 -0.04 0.02 59196652 33122598 59196652 30957648 -1776941 -2021385 172180 45497 -368794 -247570 656870 165322 -41194 57059 -189686 -97206 117468 299603 218359 2350333 2590361 147923 216586 24657 16497 24912 140465 -9833 -9990 9833 9990 9040816 3686302 10796072 11613713 -1755256 7927411 31518 9958786 31518 13622 10000000 9945164 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><b><i>1. Description of Business</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Stereotaxis designs, manufactures and markets an advanced remote robotic navigation system for use in a hospital&#8217;s interventional surgical suite, or &#8220;interventional lab&#8221;, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our products include the <i>Genesis </i>Robotic Magnetic Navigation System (&#8220;<i>Genesis</i> system&#8221;), the <i>Niobe</i> ES Robotic Magnetic Navigation System (&#8220;<i>Niobe</i> ES system&#8221;), <i>Odyssey</i> Information Management Solution (&#8220;<i>Odyssey </i>Solution&#8221;), the <i>Vdrive</i> Robotic Navigation System (&#8220;<i>Vdrive</i> system&#8221;), Stereotaxis Imaging Model S x-ray system, and related devices.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The <i>Genesis </i>and <i>Niobe</i> systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures, and reduced x-ray exposure. As of March 31, 2019, the Company had an installed base of 126 <i>Niobe</i> ES systems.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the <i>Odyssey</i> Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called <i>Odyssey Cinema</i>, which is an innovative solution delivering synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global <i>Odyssey</i> Network providing physicians with a tool for clinical collaboration, remote consultation, and training.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Our <i>Vdrive</i> system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The <i>Vdrive</i> system complements the robotic magnetic navigation systems&#8217; control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the <i>Vdrive</i> system and the <i>Vdrive Duo</i> system. In addition to the <i>Vdrive</i> system and the <i>Vdrive Duo</i> system, we also manufacture and market various disposable components which can be manipulated by these systems.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The <i>Niobe System, Odyssey Workstation, Cardiodrive,</i> and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the <i>Vdrive</i> and <i>Vdrive Duo</i> systems with the <i>V-CAS</i>, <i>V-Loop </i>and <i>V-Sono</i> devices in the U.S., Canada and Europe. The <i>Genesis </i>system and the <i>V-CAS Deflect</i> catheter advancement system have been CE Marked for sale in the Europe. Stereotaxis Imaging Model S is CE marked and FDA cleared.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">We have strategic relationships with technology leaders in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices, in order to continue to develop new solutions in the interventional lab. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. The commercial availability of currently compatible digital imaging fluoroscopy systems is unlikely to continue and efforts are being made to ensure the availability of integrated next generation systems and/or equivalent alternatives; however, we cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>2. Summary of Significant Accounting Policies</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>Basis of Presentation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>Going Concern, Liquidity and Management&#8217;s Plan</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company believes the cash on hand at March 31, 2019 will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. The Company has sustained operating losses throughout its corporate history and expects that its 2019 expenses will exceed its 2019 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. The Company&#8217;s liquidity needs will be largely determined by the success of clinical adoption within the installed base of robotic magnetic navigation systems as well as by new placements of capital systems. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>Financial Instruments</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (&#8220;Level 1&#8221;) and the lowest priority to unobservable inputs (&#8220;Level 3&#8221;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>Revenue and Costs of Revenue</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company adopted Accounting Standards Codification Topic 606 (&#8220;ASC 606&#8221;), <i>Revenue from Contracts with Customers, </i>on January 1, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><u>Systems:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company&#8217;s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented less than 1% of revenue for the three months ended March 31, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><u>Disposables:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 36% and 37% of revenue for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify"><u>Royalty:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 11% and 10% of revenue for the three months ended March 31, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><u>Other Recurring Revenue:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 50% and 53% of revenue for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify"><u>Sublease Revenue:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning with three months ended March 31, 2019. Sublease revenue represented 3% and 0% of revenue for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three Months Ended March 31,</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Systems</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">58,051</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">17,275</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Disposables, service and accessories</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,710,759</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,954,357</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Sublease</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">241,065</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total revenue</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">7,009,875</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">6,971,632</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company&#8217;s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $2.7 million as of March 31, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The following information summarizes the Company&#8217;s contract assets and liabilities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Contract Assets - Unbilled Receivables</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">268,711</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">251,867</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Customer deposits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">428,595</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">487,086</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Product shipped, revenue deferred</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">645,199</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">645,199</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Deferred service and license fees</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,976,628</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,100,402</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total deferred revenue</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,050,422</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,232,687</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Long-term deferred revenue</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(404,607</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(407,151</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total current deferred revenue</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">5,645,815</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">5,825,536</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Revenue recognized for the three months ended March 31, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $2.9 million and $2.7 million respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Assets Recognized from the Costs to Obtain a Contract with a Customer</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company has determined that sales incentive programs for the Company&#8217;s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company&#8217;s balance sheet was $0.3 million as of March 31, 2019. The Company did not incur any impairment losses during any of the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><b><i>Share-Based Compensation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><b><i>Net Income (Loss) per Common Share (&#8220;EPS&#8221;)</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the &#8220;control number&#8221; in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The following table sets forth the computation of basic and diluted EPS:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three months ended March 31,</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Net income (loss)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(2,122,820</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,435,229</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Cumulative dividend on convertible preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(353,510</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(353,589</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Net loss attributable to convertible preferred stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(610,280</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Net income (loss) attributable to common stockholders</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(2,476,330</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">471,360</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Share used for basic EPS-weighted average shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,196,652</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">30,957,648</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Restricted Stock Units</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">292,891</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Warrants</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,872,059</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Weighted average number of common shares and equivalents:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,196,652</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">33,122,598</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Basic EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.04</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.02</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Diluted EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.04</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.01</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common share for the three months ended March 31, 2019 because all such securities are anti-dilutive. <font style="background-color: white">The following potential common shares were excluded from diluted EPS for the three months ended March 31, 2018 as they were antidilutive: 1,236,445 stock options and stock appreciation rights, 280,560 restricted stock units, and 1,077,255 warrants. The Company had no unearned restricted shares during either period.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">As of March 31, 2019, the Company had 2,131,513 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.32 per share, 1,107,689 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 42,252,248 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock and accumulated dividends, and 688,687 shares of unvested restricted share units.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><b><i>Recently Issued Accounting Pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, <i>Leases (Topic 842)</i>, and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (&#8220;ASC 842&#8221;) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the &#8216;package of practical expedients&#8217;, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity&#8217;s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease Revenue and the related cost as Sublease Cost of Goods Sold. See Note 6 for additional details.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>Basis of Presentation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>Financial Instruments</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (&#8220;Level 1&#8221;) and the lowest priority to unobservable inputs (&#8220;Level 3&#8221;).</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><b><i>Share-Based Compensation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><b><i>Net Income (Loss) per Common Share (&#8220;EPS&#8221;)</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the &#8220;control number&#8221; in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The following table sets forth the computation of basic and diluted EPS:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three months ended March 31,</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Net income (loss)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(2,122,820</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,435,229</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Cumulative dividend on convertible preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(353,510</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(353,589</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Net loss attributable to convertible preferred stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(610,280</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Net income (loss) attributable to common stockholders</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(2,476,330</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">471,360</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Share used for basic EPS-weighted average shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,196,652</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">30,957,648</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Restricted Stock Units</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">292,891</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Warrants</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,872,059</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Weighted average number of common shares and equivalents:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,196,652</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">33,122,598</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Basic EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.04</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.02</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Diluted EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.04</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.01</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common share for the three months ended March 31, 2019 because all such securities are anti-dilutive. <font style="background-color: white">The following potential common shares were excluded from diluted EPS for the three months ended March 31, 2018 as they were antidilutive: 1,236,445 stock options and stock appreciation rights, 280,560 restricted stock units, and 1,077,255 warrants. The Company had no unearned restricted shares during either period.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">As of March 31, 2019, the Company had 2,131,513 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.32 per share, 1,107,689 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 42,252,248 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock and accumulated dividends, and 688,687 shares of unvested restricted share units.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"><b><i>Recently Issued Accounting Pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, <i>Leases (Topic 842)</i>, and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (&#8220;ASC 842&#8221;) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the &#8216;package of practical expedients&#8217;, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity&#8217;s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease Revenue and the related cost as Sublease Cost of Goods Sold. See Note 6 for additional details.</p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three Months Ended March 31,</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Systems</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">58,051</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">17,275</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Disposables, service and accessories</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,710,759</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,954,357</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Sublease</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">241,065</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total revenue</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">7,009,875</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">6,971,632</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The following information summarizes the Company&#8217;s contract assets and liabilities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Contract Assets - Unbilled Receivables</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">268,711</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">251,867</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Customer deposits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">428,595</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">487,086</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Product shipped, revenue deferred</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">645,199</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">645,199</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Deferred service and license fees</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,976,628</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,100,402</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total deferred revenue</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,050,422</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,232,687</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Long-term deferred revenue</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(404,607</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(407,151</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total current deferred revenue</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">5,645,815</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">5,825,536</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>3. Inventories</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">Inventories consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Raw materials</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">2,657,958</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">2,686,870</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Work in process</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">133,218</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,594</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Finished goods</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,944,522</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,963,013</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Reserve for obsolescence</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,426,564</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,460,811</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total inventory</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,309,134</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,191,666</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">Inventories consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Raw materials</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">2,657,958</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">2,686,870</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Work in process</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">133,218</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,594</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Finished goods</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,944,522</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,963,013</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Reserve for obsolescence</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,426,564</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,460,811</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total inventory</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,309,134</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,191,666</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>4. Prepaid Expenses and Other Assets</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">Prepaid expenses and other assets consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Prepaid expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">434,560</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">401,972</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Prepaid commissions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">271,664</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">304,585</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Deposits</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">237,878</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">455,508</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total prepaid expenses and other assets</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">944,102</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,162,065</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Noncurrent prepaid expenses and other assets</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(170,088</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(198,365</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total current prepaid expenses and other assets</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">774,014</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">963,700</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">Prepaid expenses and other assets consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Prepaid expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">434,560</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">401,972</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Prepaid commissions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">271,664</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">304,585</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Deposits</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">237,878</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">455,508</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total prepaid expenses and other assets</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">944,102</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,162,065</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Noncurrent prepaid expenses and other assets</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(170,088</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(198,365</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total current prepaid expenses and other assets</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">774,014</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">963,700</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>5. Property and Equipment</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">Property and equipment consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">6,841,498</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">6,831,665</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Leasehold improvements</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,592,339</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,592,339</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">9,433,837</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">9,424,004</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Accumulated depreciation</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(9,105,223</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(9,080,311</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net property and equipment</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">328,614</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">343,693</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">Property and equipment consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">6,841,498</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">6,831,665</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Leasehold improvements</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,592,339</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,592,339</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">9,433,837</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">9,424,004</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Accumulated depreciation</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(9,105,223</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(9,080,311</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net property and equipment</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">328,614</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">343,693</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>7. Accrued Liabilities</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">Accrued liabilities consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%"><font style="font-size: 10pt">Accrued salaries, bonus, and benefits</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">1,182,958</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">1,491,844</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Accrued licenses and maintenance fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">483,879</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">576,598</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Accrued warranties</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">136,946</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">149,464</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Accrued taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">188,074</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">251,988</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Accrued professional services</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">765,948</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">430,088</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">329,523</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">383,960</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Total accrued liabilities</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,087,328</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,283,942</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Long term accrued liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(813,641</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(641,461</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total current accrued liabilities</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,273,687</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,642,481</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23pt">Accrued liabilities consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%"><font style="font-size: 10pt">Accrued salaries, bonus, and benefits</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">1,182,958</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">1,491,844</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Accrued licenses and maintenance fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">483,879</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">576,598</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Accrued warranties</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">136,946</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">149,464</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Accrued taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">188,074</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">251,988</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Accrued professional services</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">765,948</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">430,088</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">329,523</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">383,960</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Total accrued liabilities</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,087,328</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,283,942</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Long term accrued liabilities</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(813,641</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(641,461</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total current accrued liabilities</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,273,687</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,642,481</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>8. Long-Term Debt and Credit Facilities</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">The Company had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The working capital line of credit matured on April 25, 2019. The revolving line of credit was secured by substantially all of the Company&#8217;s assets. The maximum available under the line was $5.0 million subject to the value of collateralized assets and the interest rate was equal to the prime rate subject to a floor of 4.5%. The Company was required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white">As of March 31, 2019, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit were made based on the borrowing capacity one week in arrears. As of March 31, 2019, the Company had a borrowing capacity of $3.3 million based on the Company&#8217;s collateralized assets. The Company&#8217;s total liquidity as of March 31, 2019, was $12.3 million which included cash and cash equivalents of $9.0 million.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>9. Convertible Preferred Stock and Stockholders&#8217; Equity</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.8pt">The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of March 31, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.8pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><b><i>Convertible Preferred Stock and Warrants</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt; background-color: white">In September 2016, the Company issued 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company&#8217;s common stock at an initial conversion rate of $0.65 per share and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Each holder of convertible preferred shares has the right to require us to redeem such holder&#8217;s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company&#8217;s assets, or the sale of more than 50% of the outstanding shares of the Company&#8217;s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a defined change of control. The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company&#8217;s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt; background-color: white">The warrants issued in conjunction with the convertible preferred stock (the &#8220;SPA Warrants&#8221;) have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants were originally puttable upon the occurrence of certain events outside of the Company&#8217;s control, and were classified as liabilities under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480-10. The calculated fair value of the warrants was periodically re-measured with any changes in value recognized in &#8220;Other income (expense)&#8221; in the Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt; background-color: white">The warrants were modified on February 28, 2018 to allow for a reduction in the exercise price from $0.70 per share to $0.28 per share for a period between March 1, 2018 and March 5, 2018. Any holder who exercised warrants at the reduced strike price was required to enter into a lock-up agreement with the Company agreeing not to sell the warrants or the common shares received upon exercise of the warrants for a period of 18 months following March 12, 2018. Additionally, the beneficial ownership limitation related to the warrants was modified and the right of holders to require the Company to redeem their SPA Warrants in exchange for cash in certain circumstances was eliminated. Following these modifications, the warrants were no longer subject to liability accounting and were reclassified to equity. During the restricted exercise period, Stereotaxis received exercise notices for 35,791,927 warrants and received an aggregate of $10.0 million in cash from the warrant exercise. As a result of these transactions, total stockholders&#8217; equity increased by $27 million and common shares outstanding increased by 35,791,927 shares. The Consent and Amendment and the Amended and Restated Form of Warrants are available in a Form 8-K filed with the Securities and Exchange Commission on March 6, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>Stock Award Plans</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt">The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the &#8220;Plan&#8221;) which was subsequently approved by the Company&#8217;s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">On June 5, 2013, June 10, 2014, May 24, 2016, and May 23, 2017, the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares, and the amendment on May 23, 2017 increased the number of shares authorized for issuance under the Plan by 4.0 million shares. At March 31, 2019, the Company had 3,246,524 remaining shares of the Company&#8217;s common stock to provide for current and future grants under its various equity plans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">At March 31, 2019, the total compensation cost related to options, stock appreciation rights, and non-vested stock granted to employees under the Company&#8217;s stock award plans but not yet recognized was approximately $2.2 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt">A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options/SARs</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Range of Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 39%"><font style="font-size: 10pt">Outstanding, December 31, 2018</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,165,086</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: center"><font style="font-size: 10pt">$0.74 - $43.90</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2.54</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">982,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">$2.03</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">2.03</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(9,625</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">$0.74 - $0.83</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.74</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Forfeited</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(5,948</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">$0.74 - $4.04</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1.59</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,131,513</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">$0.74 - $43.90</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2.32</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">A summary of the restricted stock unit activity for the three month period ended March 31, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt"><b><i>&#160;</i></b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Restricted</b></font><br /> <font style="font-size: 10pt"><b>Stock Units</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Grant Date Fair Value per Unit</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%"><font style="font-size: 10pt">Outstanding, December 31, 2018</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 22%; text-align: right"><font style="font-size: 10pt">647,649</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 22%; text-align: right"><font style="font-size: 10pt">0.83</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">210,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.19</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Vested</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(166,962</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.12</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Forfeited</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.72</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">688,687</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.87</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt">A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options/SARs</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Range of Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 39%"><font style="font-size: 10pt">Outstanding, December 31, 2018</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,165,086</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: center"><font style="font-size: 10pt">$0.74 - $43.90</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2.54</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">982,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">$2.03</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">2.03</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(9,625</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">$0.74 - $0.83</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.74</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Forfeited</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(5,948</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">$0.74 - $4.04</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1.59</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,131,513</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">$0.74 - $43.90</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2.32</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 23.05pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">A summary of the restricted stock unit activity for the three month period ended March 31, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt"><b><i>&#160;</i></b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Restricted</b></font><br /> <font style="font-size: 10pt"><b>Stock Units</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Grant Date Fair Value per Unit</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%"><font style="font-size: 10pt">Outstanding, December 31, 2018</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 22%; text-align: right"><font style="font-size: 10pt">647,649</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 22%; text-align: right"><font style="font-size: 10pt">0.83</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">210,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.19</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Vested</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(166,962</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.12</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Forfeited</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.72</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">688,687</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.87</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>10. Product Warranty Provisions</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in">The Company&#8217;s standard policy is to warrant all capital systems against defects in material or workmanship for one year following installation. The Company&#8217;s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in">Accrued warranty, which is included in other accrued liabilities, consists of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Warranty accrual, beginning of the fiscal period</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">149,464</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">164,365</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Accrual adjustment for product warranty</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">17,135</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">34,253</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Payments made</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(29,653</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(49,154</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Warranty accrual, end of the fiscal period</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">136,946</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">149,464</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt">Accrued warranty, which is included in other accrued liabilities, consists of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 21.6pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Warranty accrual, beginning of the fiscal period</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">149,464</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">164,365</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Accrual adjustment for product warranty</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">17,135</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">34,253</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Payments made</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(29,653</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(49,154</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Warranty accrual, end of the fiscal period</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">136,946</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">149,464</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> 59321209 true false false STXS 5645815 5825536 2590361 -182265 1382082 22805731 59058297 23900 23900 23900 23880 58901126 59308237 17806 14625 15064 13531 17 15 13514 15049 35791927 33087 16423 26929783 35792 33 26893991 16390 294562 294562 126 0.01 0.01 0.36 0.37 0.11 0.10 0.50 0.53 0.03 0.00 2700000 2900000 2700000 300000 P4Y 2131513 1165086 2131513 42252248 2.32 2.54 2.32 0.70 0.28 0.70 0.70 647649 688687 404607 407151 6050422 268711 251867 645199 645199 4976628 5100402 428595 487086 6232687 2657958 2686870 133218 2594 2944522 2963013 4426564 4460811 434560 401972 271664 304585 237878 455508 944102 1162065 170088 198365 9433837 6841498 6831665 2592339 2592339 9424004 9105223 9080311 1182958 1491844 483879 576598 136946 164365 149464 188074 251988 765948 430088 329523 383960 3087328 3283942 813641 641461 5000000 3300000 1 24000 0.001 0.65 36923078 0.06 0.50 2021-09-29 27000000 9625 2200000 P4Y 1000000 1000000 1500000 4000000 3246524 982000 5948 0.74 0.74 0.74 0.74 43.90 2.03 0.83 4.04 43.90 2.03 0.74 1.59 210000 166962 2000 0.83 0.87 1.19 1.12 0.72 353510 353589 1236445 280560 1077255 P1Y 17135 34253 29653 49154 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><b><i>6. Leases</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.5pt"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU No. 2016-02 <i>&#8220;Leases&#8221; (Topic 842)</i> and all subsequent ASUs that modified Topic 842. The Company determines if an arrangement contains a lease at inception. For the Company, Accounting Standards Codification (&#8220;ASC 842&#8221;) primarily affected the accounting treatment for operating lease agreements in which the Company is the lessee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company leases its facilities under operating leases, which were previously not recognized on the Company&#8217;s balance sheets. With the adoption of ASC 842, operating lease agreements are required to be recognized on the balance sheet as a right-of-use (&#8220;ROU&#8221;) asset and a corresponding lease liability. These leases do not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. A portion of our principal executive office is subleased to a third party through 2021. The sublease does not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. In addition, the sublease does not contain contingent rent provisions nor are there options to extend or terminate the sublease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company&#8217;s lease agreements often include one or more options to renew at the Company&#8217;s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e., leases with initial terms of twelve months or less) on the balance sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception. At March 31, 2019, the weighted average discount rate for operating leases was 9.0% and the weighted average remaining lease term for operating lease term is 2.75 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The following table represents lease costs and other lease information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font-size: 10pt">Operating lease cost</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">585,586</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Short-term lease cost</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">19,809</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Sublease income</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(241,065</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total lease cost</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">364,330</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Cash paid within operating cash flows</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">615,266</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The initial recognition of the right of use assets was $6.2 million. Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment which are paid based on actual costs incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2019, excluding sublease income, were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font-size: 10pt">2019</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">1,717,837</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">2020</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,339,810</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,382,661</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">2022 and thereafter</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Total lease payments</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">6,440,308</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">Less: Interest</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(846,934</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Present value of lease liabilities</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,593,374</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The undiscounted future cash flows to be received under the sublease are $0.7 million in 2019, $1.0 million in 2020 and $1.0 million in 2021.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>11. Commitments and Contingencies</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 21.6pt">The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The following table sets forth the computation of basic and diluted EPS:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three months ended March 31,</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Net income (loss)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(2,122,820</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,435,229</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Cumulative dividend on convertible preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(353,510</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(353,589</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Net loss attributable to convertible preferred stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(610,280</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Net income (loss) attributable to common stockholders</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(2,476,330</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">471,360</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Share used for basic EPS-weighted average shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,196,652</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">30,957,648</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Restricted Stock Units</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">292,891</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Warrants</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,872,059</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Weighted average number of common shares and equivalents:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,196,652</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">33,122,598</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Basic EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.04</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.02</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Diluted EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.04</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.01</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2019, excluding sublease income, were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font-size: 10pt">2019</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">1,717,837</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">2020</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,339,810</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,382,661</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">2022 and thereafter</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Total lease payments</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">6,440,308</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">Less: Interest</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(846,934</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Present value of lease liabilities</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,593,374</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> 35791927 5580457 3433430 2159944 241065 147954 216674 286 167 216388 147787 285662 166962 -20 35266 5121 -5121 35 5086 567857 -567857 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify"><b><i>12. Subsequent Events</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">None.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table represents lease costs and other lease information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font-size: 10pt">Operating lease cost</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">585,586</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Short-term lease cost</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">19,809</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Sublease income</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(241,065</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total lease cost</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">364,330</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Cash paid within operating cash flows</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">615,266</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i></i></b></p> 7009875 58051 6710759 17275 6954357 6971632 292891 1872059 0.090 P2Y9M 700000 1000000 1000000 5593374 585586 19809 364330 615266 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>Going Concern, Liquidity and Management&#8217;s Plan</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company believes the cash on hand at March 31, 2019 will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. The Company has sustained operating losses throughout its corporate history and expects that its 2019 expenses will exceed its 2019 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. The Company&#8217;s liquidity needs will be largely determined by the success of clinical adoption within the installed base of robotic magnetic navigation systems as well as by new placements of capital systems. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Assets Recognized from the Costs to Obtain a Contract with a Customer</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company has determined that sales incentive programs for the Company&#8217;s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company&#8217;s balance sheet was $0.3 million as of March 31, 2019. The Company did not incur any impairment losses during any of the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>Revenue and Costs of Revenue</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 12.2pt; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company adopted Accounting Standards Codification Topic 606 (&#8220;ASC 606&#8221;), <i>Revenue from Contracts with Customers, </i>on January 1, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><u>Systems:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company&#8217;s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented less than 1% of revenue for the three months ended March 31, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><u>Disposables:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 36% and 37% of revenue for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify"><u>Royalty:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 11% and 10% of revenue for the three months ended March 31, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><u>Other Recurring Revenue:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 50% and 53% of revenue for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify"><u>Sublease Revenue:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt; text-align: justify">The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning with three months ended March 31, 2019. Sublease revenue represented 3% and 0% of revenue for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three Months Ended March 31,</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Systems</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">58,051</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">17,275</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Disposables, service and accessories</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,710,759</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,954,357</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Sublease</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">241,065</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#8212;</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total revenue</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">7,009,875</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">6,971,632</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company&#8217;s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $2.7 million as of March 31, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The following information summarizes the Company&#8217;s contract assets and liabilities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2019</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Contract Assets - Unbilled Receivables</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">268,711</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">251,867</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Customer deposits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">428,595</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">487,086</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Product shipped, revenue deferred</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">645,199</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">645,199</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Deferred service and license fees</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,976,628</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,100,402</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total deferred revenue</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,050,422</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,232,687</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Long-term deferred revenue</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(404,607</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(407,151</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total current deferred revenue</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">5,645,815</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">5,825,536</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">Revenue recognized for the three months ended March 31, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $2.9 million and $2.7 million respectively.</p> 1107689 2019-04-25 0.045 35791927 610280 1717837 2339810 2382661 6440308 846934 246530 12300000 Represents the adjustments related to the adoption of new accounting standards. See Note 2 for details. EX-101.SCH 7 stxs-20190331.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Prepaid Expenses and Other Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Long-Term Debt and Credit Facilities link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Convertible Preferred Stock and Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Product Warranty Provisions link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Prepaid Expenses and Other Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Product Warranty Provisions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Description of Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Type (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Prepaid Expenses and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Leases - Schedule of Lease Costs and Other Lease Information (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Leases - Schedule of Future Minimum Operating Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Long-Term Debt and Credit Facilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Summary of Option and Stock Appreciation Rights Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Summary of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Product Warranty Provisions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Product Warranty Provisions - Schedule of Accrued Warranty (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 stxs-20190331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 stxs-20190331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 stxs-20190331_lab.xml XBRL LABEL FILE Product and Service [Axis] Systems [Member] Disposables, Service and Accessories [Member] Contract Assets - Unbilled Receivables [Member] Product Shipped, Revenue Deferred [Member] Deferred Service and License Fees [Member] Property, Plant and Equipment, Type [Axis] Equipment [Member] Leasehold Improvements [Member] Credit Facility [Axis] Revolving Credit Facility [Member] Exercise Price Range [Axis] Range One [Member] Range Two [Member] Range Three [Member] Range Four [Member] Plan Name [Axis] 2012 Stock Incentive Plan [Member] Award Type [Axis] Restricted Stock Units [Member] Range [Axis] Minimum [Member] Maximum [Member] Range Five [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-In Capital [Member] Treasury Stock [Member] Accumulated Deficit [Member] Class of Stock [Axis] Convertible Preferred Stock [Member] Customer Deposits [Member] Series A Convertible Preferred Stock [Member] Warrant [Member] Concentration Risk Benchmark [Axis] Revenue from System Delivery and Installation [Member] Disposable Revenue [Member] Royalty Revenue [Member] Other Recurring Revenue [Member] Sublease Revenue [Member] Antidilutive Securities [Axis] Stock Options and Stock Appreciation Rights [Member] Title of Individual [Axis] Primary Lender [Member] Variable Rate [Axis] Prime Rate [Member] Income Tax Authority [Axis] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Accounts receivable, net of allowance of $458,701 and $398,847 in 2019 and 2018, respectively Inventories, net Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease right-of-use assets Other assets Total assets Liabilities and stockholders' equity (deficit) Current liabilities: Accounts payable Accrued liabilities Deferred revenue Current portion of operating lease liabilities Total current liabilities Long-term deferred revenue Operating lease liabilities Other liabilities Total liabilities Convertible preferred stock: Convertible preferred stock, par value $0.001; 10,000,000 shares authorized, 23,880 and 23,900 shares outstanding at 2019 and 2018 Stockholders' equity (deficit): Common stock, par value $0.001; 300,000,000 shares authorized, 59,308,237 and 59,058,297 shares issued at 2019 and 2018, respectively Additional paid in capital Treasury stock, 4,015 shares at 2019 and 2018 Accumulated deficit Total stockholders' equity (deficit) Total liabilities and stockholders' equity (deficit) Accounts receivable, allowance Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Treasury stock, shares Statement [Table] Statement [Line Items] Revenue: Sublease Total revenue Cost of revenue: Sublease Total cost of revenue Gross margin Operating expenses: Research and development Sales and marketing General and administrative Total operating expenses Operating loss Other income Interest income (expense) Net income (loss) Cumulative dividend on convertible preferred stock Net income attributable to convertible preferred stock Earnings (loss) attributable to common stockholders Net income (loss) per share attributable to common stockholders: Basic Diluted Weighted average number of common shares and equivalents: Basic Diluted Beginning Balance Beginning Balance, Shares Issuance of common stock and warrants Issuance of common stock and warrants, Shares Share-based compensation Share-based compensation, shares Components of net income (loss) Employee stock purchase plan Employee stock purchase plan, Shares Cumulative catchup for adoption of ASC 606 Preferred stock conversion Preferred stock conversion, shares Ending Balance Ending Balance, Shares Statement of Cash Flows [Abstract] Cash flows from operating activities Net income (loss) Adjustments to reconcile net income (loss) to cash used in operating activities: Depreciation Amortization of intangibles Amortization of deferred finance costs Amortization of right-of-use asset Share-based compensation Adjustment of warrants Changes in operating assets and liabilities: Accounts receivable Inventories Prepaid expenses and other current assets Other assets Accounts payable Accrued liabilities Deferred revenue Operating lease liability Other liabilities Net cash used in operating activities Cash flows from investing activities Purchase of fixed assets Net cash used in investing activities Cash flows from financing activities Proceeds from issuance of stock, net of issuance costs Proceeds from warrant exercise Net cash provided by financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Organization, Consolidation and Presentation of Financial Statements [Abstract] Description of Business Accounting Policies [Abstract] Summary of Significant Accounting Policies Inventory Disclosure [Abstract] Inventories Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepaid Expenses and Other Assets Property, Plant and Equipment [Abstract] Property and Equipment Leases [Abstract] Leases Payables and Accruals [Abstract] Accrued Liabilities Debt Disclosure [Abstract] Long-Term Debt and Credit Facilities Stockholders' Equity Note [Abstract] Convertible Preferred Stock and Stockholders' Equity Product Warranties Disclosures [Abstract] Product Warranty Provisions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Basis of Presentation Going Concern, Liquidity and Management's Plan Financial Instruments Revenue and Costs of Revenue Assets Recognized from the Costs to Obtain a Contract with a Customer Share-Based Compensation Net Income (Loss) Per Common Share ("EPS") Recently Issued Accounting Pronouncements Schedule of Revenue Disaggregated by Type Summary of Contract Assets and Liabilities Computation of Basic and Diluted Earnings Per Share Schedule of Inventories Schedule of Prepaid Expenses and Other Assets Schedule of Property and Equipment Schedule of Lease Costs and Other Lease Information Schedule of Future Minimum Operating Lease Payments Schedule of Accrued Liabilities Summary of Option and Stock Appreciation Rights Activity Summary of Restricted Stock Unit Activity Schedule of Accrued Warranty Installed base Revenues percentage Remaining performance obligation Revenue recognized Capitalized contract acquisition costs Share-based compensation, requisite service period Potential common shares excluded from diluted earning per share Options and stock appreciation rights Weighted average exercise price Common stock issuable upon exercise, warrants Exercise price of warrants Unvested restricted shares Total deferred revenue Less: Long-term deferred revenue Total current deferred revenue Net loss attributable to convertible preferred stock Net income (loss) attributable to common stockholders Share used for basic EPS-weighted average shares Restricted Stock Units Warrants Weighted average number of common shares and equivalents: Basic EPS Diluted EPS Raw materials Work in process Finished goods Reserve for obsolescence Total inventory Prepaid expenses Prepaid commissions Deposits Total prepaid expenses and other assets Less: Noncurrent prepaid expenses and other assets Total current prepaid expenses and other assets Gross property and equipment Less: Accumulated depreciation Net property and equipment Weighted average discount rate for operating leases Weighted average remaining lease term for operating lease term Right of use assets Undiscounted future cash flows to be received under the sublease 2019 undiscounted future cash flows to be received under the sublease 2020 undiscounted future cash flows to be received under the sublease 2021 Operating lease cost Short-term lease cost Sublease income Total lease cost Cash paid within operating cash flows 2019 2020 2021 2022 and thereafter Total lease payments Less: Interest Present value of lease liabilities Accrued salaries, bonus, and benefits Accrued licenses and maintenance fees Accrued warranties Accrued taxes Accrued professional services Other Total accrued liabilities Less: Long term accrued liabilities Total current accrued liabilities Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Line of credit maturity date Line of credit facility, maximum borrowing capacity Line of credit interest rate Line of credit facility, current borrowing capacity Total liquidity Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Statistical Measurement [Axis] Number of stockholders votes Dividends declared Dividends paid Number of preferred stock issued Preferred stock, par value Preferred stock, stated value Preferred stock, conversion price Common stock issuable from warrants Preferred stock dividend rate Preferred stock redemption, triggering event, percent of common stock sold threshold Warrants exercisable date Number of restricted warrants exercise Increased in stockholders' equity Increased in common shares outstanding Increase in number of shares authorized for issuance under the plan Remaining shares available for issuance Total compensation cost not yet recognized Weighted average amortization period of total compensation cost not yet recognized Number of Options/SARs, Outstanding, Beginning Balance Number of Options/SARs, Granted Number of Options/SARs, Exercised Number of Options/SARs, Forfeited Number of Options/SARs, Outstanding, Ending Balance Range of Exercise Price, Lower Limit Range of Exercise Price, Upper Limit Weighted Average Exercise Price per Share, Outstanding, Beginning Balance Weighted Average Exercise Price per Share, Granted Weighted Average Exercise Price per Share, Exercised Weighted Average Exercise Price per Share, Forfeited Weighted Average Exercise Price per Share, Outstanding, Ending Balance Number of Restricted Stock Units, Outstanding, December 31, 2018 Number of Restricted Stock Units, Granted Number of Restricted Stock Units, Vested Number of Restricted Stock Units, Forfeited Number of Restricted Stock Units, Outstanding, March 31, 2019 Weighted Average Grant Date Fair Value per Unit, Outstanding, December 31, 2018 Weighted Average Grant Date Fair Value per Unit, Granted Weighted Average Grant Date Fair Value per Unit, Vested Weighted Average Grant Date Fair Value per Unit, Forfeited Weighted Average Grant Date Fair Value per Unit, Outstanding, March 31, 2019 Standard product warranty coverage term Warranty accrual, beginning of the fiscal period Accrual adjustment for product warranty Payments made Warranty accrual, end of the fiscal period Carrying value as of the balance sheet date of obligations incurred through that date and payable for license and maintenance fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Issuance of common stock and warrants, shares. Biosense Webster Inc [Member] Contract Assets - Unbilled Receivables [Member] Country Other Than U.S. [Member] Customer Deposits [Member] Customer [Member] Deferred Service and License Fees [Member] Demonstration And Assembly [Member] Disposable Revenue [Member] Disposables, Service and Accessories [Member] Stock Option and Stock Appreciation Rights (SARs) [Member] Employee Stock Purchase Plan (&amp;#8220;ESPP&amp;#8221;) [Member] Exchange Warrants [Member] January 10, 2019 [Member] New Directors [Member] Non-employee Directors [Member] Non-Streamline Period [Member] Number of restrcited warrants exercise. Number of stockholders votes. Office Sublease [Member] Options to Purchase Common Stock [Member] Other Recurring Revenue [Member] Preferred stock par value per share. Preferred stock redemption, triggering event, Percent of common stock sold threshold Prepaid commissions, Current And Noncurrent Product Shipped, Revenue Deferred [Member] Range Five [Member]. PIPE Warrants [Member] Range of Exercise Prices Five [Member] Range of Exercise Prices Four [Member] Range of Exercise Prices One [Member] Range of Exercise Prices Seven [Member] Range of Exercise Prices Six [Member] Range of Exercise Prices Three [Member] Range of Exercise Prices Two [Member] PIPE Warrants [Member] PIPE Warrants [Member] PIPE Warrants [Member] Revenue from System Delivery and Installation [Membe Royalty Revenue [Member] Series A Convertible Preferred Stock and Accumulated Dividends [Member] Series A Convertible Preferred Stock [Membe Series A Convertible Preferred Stock Series [Member] Standard product warranty, coverage term Stock Award Plans [Member] Streamline Period [Member] The total number Niobe ES systems installed. Systems [Member] Time-Based Restricted Shares [Member] 2012 Stock Incentive Plan [Member] 2009 Employee Stock Purchase Plan ("ESPP") [Member] Unimproved Space [Member] Warrants Issued August 2013 [Member] Warrants Issued September 2016 [Member] Going Concern, Liquidity and Management's Plan [Policy Text Block] Contract Asset And Liability [Policy Text Block] Sublease Revenue [Member]. Warrants. Stock Options and Stock Appreciation Rights [Member] Primary Lender [Member] Increased in common shares outstanding. Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year. Cost of subleased portion of operating lease. Assets, Current Assets [Default Label] Liabilities, Current Liabilities Treasury Stock, Common, Value Stockholders' Equity Attributable to Parent Liabilities and Equity CostOfSublease Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Preferred Stock Dividends, Income Statement Impact Weighted Average Number of Shares Outstanding, Diluted Common Stock, Shares, Outstanding Share-based Payment Arrangement, Noncash Expense Derivative, Gain (Loss) on Derivative, Net Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Other Operating Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability Increase (Decrease) in Other Operating Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Productive Assets Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Inventory Valuation Reserves Prepaid Expense and Other Assets Prepaid Expense and Other Assets, Noncurrent Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Lease, Cost Lessee, Operating Lease, Liability, Payments, Due Lessee, Operating Lease, Liability, Undiscounted Excess Amount Accrued Liabilities [Default Label] Other Accrued Liabilities, Noncurrent PreferredStockParValuePerShare Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Standard and Extended Product Warranty Accrual, Decrease for Payments EX-101.PRE 11 stxs-20190331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2019
Apr. 30, 2019
Document And Entity Information    
Entity Registrant Name Stereotaxis, Inc.  
Entity Central Index Key 0001289340  
Document Type 10-Q  
Document Period End Date Mar. 31, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   59,321,209
Trading Symbol STXS  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2019  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 9,040,816 $ 10,796,072
Accounts receivable, net of allowance of $458,701 and $398,847 in 2019 and 2018, respectively 5,239,470 5,021,111
Inventories, net 1,309,134 1,191,666
Prepaid expenses and other current assets 774,014 963,700
Total current assets 16,363,434 17,972,549
Property and equipment, net 328,614 343,693
Operating lease right-of-use assets 5,580,457
Other assets 170,088 198,365
Total assets 22,442,593 18,514,607
Current liabilities:    
Accounts payable 2,383,230 1,726,360
Accrued liabilities 2,273,687 2,642,481
Deferred revenue 5,645,815 5,825,536
Current portion of operating lease liabilities 2,159,944
Total current liabilities 12,462,676 10,194,377
Long-term deferred revenue 404,607 407,151
Operating lease liabilities 3,433,430
Other liabilities 813,641 641,461
Total liabilities 17,114,354 11,242,989
Convertible preferred stock:    
Convertible preferred stock, par value $0.001; 10,000,000 shares authorized, 23,880 and 23,900 shares outstanding at 2019 and 2018 5,955,354 5,960,475
Stockholders' equity (deficit):    
Common stock, par value $0.001; 300,000,000 shares authorized, 59,308,237 and 59,058,297 shares issued at 2019 and 2018, respectively 59,308 59,058
Additional paid in capital 478,363,886 478,179,574
Treasury stock, 4,015 shares at 2019 and 2018 (205,999) (205,999)
Accumulated deficit (478,844,310) (476,721,490)
Total stockholders' equity (deficit) (627,115) 1,311,143
Total liabilities and stockholders' equity (deficit) $ 22,442,593 $ 18,514,607
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Balance Sheets (Parenthetical) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 458,701 $ 398,847
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares outstanding 23,880 23,900
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 59,308,237 59,058,297
Treasury stock, shares 4,015 4,015
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue:    
Sublease $ 241,065
Total revenue 7,009,875 6,971,632
Cost of revenue:    
Sublease 246,530
Total cost of revenue 1,412,053 1,265,347
Gross margin 5,597,822 5,706,285
Operating expenses:    
Research and development 2,959,219 1,962,626
Sales and marketing 3,309,829 3,634,997
General and administrative 1,468,160 1,239,179
Total operating expenses 7,737,208 6,836,802
Operating loss (2,139,386) (1,130,517)
Other income 2,590,361
Interest income (expense) 16,566 (24,615)
Net income (loss) (2,122,820) 1,435,229
Cumulative dividend on convertible preferred stock (353,510) (353,589)
Net income attributable to convertible preferred stock (610,280)
Earnings (loss) attributable to common stockholders $ (2,476,330) $ 471,360
Net income (loss) per share attributable to common stockholders:    
Basic $ (0.04) $ 0.02
Diluted $ (0.04) $ 0.01
Weighted average number of common shares and equivalents:    
Basic 59,196,652 30,957,648
Diluted 59,196,652 33,122,598
Systems [Member]    
Revenue:    
Total revenue $ 58,051 $ 17,275
Cost of revenue:    
Total cost of revenue 51,163 203,602
Disposables, Service and Accessories [Member]    
Revenue:    
Total revenue 6,710,759 6,954,357
Cost of revenue:    
Total cost of revenue $ 1,114,360 $ 1,061,745
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Total
Beginning Balance at Dec. 31, 2017 $ 5,960,475 $ 22,806 $ 450,748,403 $ (205,999) $ (477,132,808) $ (26,567,598)
Beginning Balance, Shares at Dec. 31, 2017 23,900 22,805,731    
Issuance of common stock and warrants $ 35,792 26,893,991 26,929,783
Issuance of common stock and warrants, Shares 35,791,927    
Share-based compensation $ 286 $ 216,388 216,674
Share-based compensation, shares 285,662  
Components of net income (loss) $ 1,435,228 1,435,229
Employee stock purchase plan $ 17 13,514 13,531
Employee stock purchase plan, Shares 17,806    
Cumulative catchup for adoption of ASC 606 $ 294,562 [1] 294,562 [1]
Ending Balance at Mar. 31, 2018 $ 5,960,475 $ 58,901 477,872,296 (205,999) (475,403,018) 2,322,180
Ending Balance, Shares at Mar. 31, 2018 23,900 58,901,126        
Beginning Balance at Dec. 31, 2018 $ 5,960,475 $ 59,058 478,179,574 $ (205,999) $ (476,721,490) $ 1,311,143
Beginning Balance, Shares at Dec. 31, 2018 23,900 59,058,297  
Issuance of common stock and warrants $ 33 $ 16,390 $ 16,423
Issuance of common stock and warrants, Shares 33,087
Share-based compensation $ 167 $ 147,787 $ 147,954
Share-based compensation, shares 166,962
Components of net income (loss) $ (2,122,820) $ (2,122,820)
Employee stock purchase plan $ 15 $ 15,049 $ 15,064
Employee stock purchase plan, Shares 14,625
Preferred stock conversion $ (5,121) $ 35 $ 5,086 $ 5,121
Preferred stock conversion, shares (20) 35,266
Ending Balance at Mar. 31, 2019 $ 5,955,354 $ 59,308 $ 478,363,886 $ (205,999) $ (478,844,310) $ (627,115)
Ending Balance, Shares at Mar. 31, 2019 23,880 59,308,237        
[1] Represents the adjustments related to the adoption of new accounting standards. See Note 2 for details.
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities    
Net income (loss) $ (2,122,820) $ 1,435,229
Adjustments to reconcile net income (loss) to cash used in operating activities:    
Depreciation 24,912 140,465
Amortization of intangibles 16,497
Amortization of deferred finance costs 24,657
Amortization of right-of-use asset 567,857
Share-based compensation 147,923 216,586
Adjustment of warrants (2,590,361)
Changes in operating assets and liabilities:    
Accounts receivable (218,359) (2,350,333)
Inventories (117,468) (299,603)
Prepaid expenses and other current assets 189,686 97,206
Other assets 41,194 (57,059)
Accounts payable 656,870 165,322
Accrued liabilities (368,794) (247,570)
Deferred revenue (182,265) 1,382,082
Operating lease liability (567,857)
Other liabilities 172,180 45,497
Net cash used in operating activities (1,776,941) (2,021,385)
Cash flows from investing activities    
Purchase of fixed assets (9,833) (9,990)
Net cash used in investing activities (9,833) (9,990)
Cash flows from financing activities    
Proceeds from issuance of stock, net of issuance costs 31,518 13,622
Proceeds from warrant exercise 9,945,164
Net cash provided by financing activities 31,518 9,958,786
Net increase (decrease) in cash and cash equivalents (1,755,256) 7,927,411
Cash and cash equivalents at beginning of period 10,796,072 3,686,302
Cash and cash equivalents at end of period $ 9,040,816 $ 11,613,713
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Description of Business
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business

1. Description of Business

 

Stereotaxis designs, manufactures and markets an advanced remote robotic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our products include the Genesis Robotic Magnetic Navigation System (“Genesis system”), the Niobe ES Robotic Magnetic Navigation System (“Niobe ES system”), Odyssey Information Management Solution (“Odyssey Solution”), the Vdrive Robotic Navigation System (“Vdrive system”), Stereotaxis Imaging Model S x-ray system, and related devices.

 

The Genesis and Niobe systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures, and reduced x-ray exposure. As of March 31, 2019, the Company had an installed base of 126 Niobe ES systems.

 

In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the Odyssey Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution delivering synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and training.

 

Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the robotic magnetic navigation systems’ control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the Vdrive system and the Vdrive Duo system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components which can be manipulated by these systems.

 

We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.

 

The Niobe System, Odyssey Workstation, Cardiodrive, and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and Europe. The Genesis system and the V-CAS Deflect catheter advancement system have been CE Marked for sale in the Europe. Stereotaxis Imaging Model S is CE marked and FDA cleared.

 

We have strategic relationships with technology leaders in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices, in order to continue to develop new solutions in the interventional lab. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. The commercial availability of currently compatible digital imaging fluoroscopy systems is unlikely to continue and efforts are being made to ensure the availability of integrated next generation systems and/or equivalent alternatives; however, we cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.

 

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.

 

Going Concern, Liquidity and Management’s Plan

 

The Company believes the cash on hand at March 31, 2019 will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. The Company has sustained operating losses throughout its corporate history and expects that its 2019 expenses will exceed its 2019 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of robotic magnetic navigation systems as well as by new placements of capital systems. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.

 

Financial Instruments

 

Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).

 

Revenue and Costs of Revenue

 

The Company adopted Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from Contracts with Customers, on January 1, 2018.

 

We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented less than 1% of revenue for the three months ended March 31, 2019 and 2018.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 36% and 37% of revenue for the three months ended March 31, 2019 and 2018, respectively.

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 11% and 10% of revenue for the three months ended March 31, 2019 and 2018.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 50% and 53% of revenue for the three months ended March 31, 2019 and 2018, respectively.

 

Sublease Revenue:

 

The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning with three months ended March 31, 2019. Sublease revenue represented 3% and 0% of revenue for the three months ended March 31, 2019 and 2018, respectively.

 

    Three Months Ended March 31,  
    2019     2018  
Systems   $ 58,051     $ 17,275  
Disposables, service and accessories     6,710,759       6,954,357  
Sublease     241,065        
Total revenue   $ 7,009,875     $ 6,971,632  

 

Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $2.7 million as of March 31, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.

 

The following information summarizes the Company’s contract assets and liabilities:

 

    March 31, 2019     December 31, 2018  
Contract Assets - Unbilled Receivables   $ 268,711     $ 251,867  
                 
Customer deposits     428,595       487,086  
Product shipped, revenue deferred     645,199       645,199  
Deferred service and license fees     4,976,628       5,100,402  
Total deferred revenue     6,050,422       6,232,687  
Less: Long-term deferred revenue     (404,607 )     (407,151 )
Total current deferred revenue   $ 5,645,815     $ 5,825,536  

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Revenue recognized for the three months ended March 31, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $2.9 million and $2.7 million respectively.

 

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $0.3 million as of March 31, 2019. The Company did not incur any impairment losses during any of the periods presented.

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

 

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

 

Net Income (Loss) per Common Share (“EPS”)

 

Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

 

The following table sets forth the computation of basic and diluted EPS:

 

    Three months ended March 31,  
    2019     2018  
Net income (loss)   $ (2,122,820 )   $ 1,435,229  
Cumulative dividend on convertible preferred stock     (353,510 )     (353,589 )
Net loss attributable to convertible preferred stock           (610,280 )
Net income (loss) attributable to common stockholders   $ (2,476,330 )   $ 471,360  
                 
Share used for basic EPS-weighted average shares     59,196,652       30,957,648  
Restricted Stock Units           292,891  
Warrants           1,872,059  
Weighted average number of common shares and equivalents:     59,196,652       33,122,598  
Basic EPS   $ (0.04 )   $ 0.02  
Diluted EPS   $ (0.04 )   $ 0.01  

 

The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common share for the three months ended March 31, 2019 because all such securities are anti-dilutive. The following potential common shares were excluded from diluted EPS for the three months ended March 31, 2018 as they were antidilutive: 1,236,445 stock options and stock appreciation rights, 280,560 restricted stock units, and 1,077,255 warrants. The Company had no unearned restricted shares during either period.

 

As of March 31, 2019, the Company had 2,131,513 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.32 per share, 1,107,689 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 42,252,248 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock and accumulated dividends, and 688,687 shares of unvested restricted share units.

 

Recently Issued Accounting Pronouncements

 

Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (“ASC 842”) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity’s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease Revenue and the related cost as Sublease Cost of Goods Sold. See Note 6 for additional details.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Inventories
3 Months Ended
Mar. 31, 2019
Inventory Disclosure [Abstract]  
Inventories

3. Inventories

 

Inventories consist of the following:

 

    March 31, 2019     December 31, 2018  
             
Raw materials   $ 2,657,958     $ 2,686,870  
Work in process     133,218       2,594  
Finished goods     2,944,522       2,963,013  
Reserve for obsolescence     (4,426,564 )     (4,460,811 )
Total inventory   $ 1,309,134     $ 1,191,666  

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Prepaid Expenses and Other Assets
3 Months Ended
Mar. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid Expenses and Other Assets

4. Prepaid Expenses and Other Assets

 

Prepaid expenses and other assets consist of the following:

 

    March 31, 2019     December 31, 2018  
             
Prepaid expenses   $ 434,560     $ 401,972  
Prepaid commissions     271,664       304,585  
Deposits     237,878       455,508  
Total prepaid expenses and other assets     944,102       1,162,065  
Less: Noncurrent prepaid expenses and other assets     (170,088 )     (198,365 )
Total current prepaid expenses and other assets   $ 774,014     $ 963,700  

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Property and Equipment
3 Months Ended
Mar. 31, 2019
Property, Plant and Equipment [Abstract]  
Property and Equipment

5. Property and Equipment

 

Property and equipment consist of the following:

 

    March 31, 2019     December 31, 2018  
             
Equipment   $ 6,841,498     $ 6,831,665  
Leasehold improvements     2,592,339       2,592,339  
      9,433,837       9,424,004  
Less: Accumulated depreciation     (9,105,223 )     (9,080,311 )
Net property and equipment   $ 328,614     $ 343,693  

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Leases
3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Leases

6. Leases

 

A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842. The Company determines if an arrangement contains a lease at inception. For the Company, Accounting Standards Codification (“ASC 842”) primarily affected the accounting treatment for operating lease agreements in which the Company is the lessee.

 

The Company leases its facilities under operating leases, which were previously not recognized on the Company’s balance sheets. With the adoption of ASC 842, operating lease agreements are required to be recognized on the balance sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases do not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. A portion of our principal executive office is subleased to a third party through 2021. The sublease does not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. In addition, the sublease does not contain contingent rent provisions nor are there options to extend or terminate the sublease.

 

The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e., leases with initial terms of twelve months or less) on the balance sheet.

 

The calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception. At March 31, 2019, the weighted average discount rate for operating leases was 9.0% and the weighted average remaining lease term for operating lease term is 2.75 years.

 

The following table represents lease costs and other lease information.

 

    Three Months Ended  
    March 31, 2019  
       
Operating lease cost   $ 585,586  
Short-term lease cost     19,809  
Sublease income     (241,065 )
Total lease cost   $ 364,330  
         
Cash paid within operating cash flows   $ 615,266  

 

The initial recognition of the right of use assets was $6.2 million. Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment which are paid based on actual costs incurred.

 

Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2019, excluding sublease income, were as follows:

 

    March 31, 2019  
       
2019   $ 1,717,837  
2020     2,339,810  
2021     2,382,661  
2022 and thereafter     -  
Total lease payments   $ 6,440,308  
Less: Interest     (846,934 )
Present value of lease liabilities   $ 5,593,374  

 

The undiscounted future cash flows to be received under the sublease are $0.7 million in 2019, $1.0 million in 2020 and $1.0 million in 2021.

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Accrued Liabilities
3 Months Ended
Mar. 31, 2019
Payables and Accruals [Abstract]  
Accrued Liabilities

7. Accrued Liabilities

 

Accrued liabilities consist of the following:

 

    March 31, 2019     December 31, 2018  
             
Accrued salaries, bonus, and benefits   $ 1,182,958     $ 1,491,844  
Accrued licenses and maintenance fees     483,879       576,598  
Accrued warranties     136,946       149,464  
Accrued taxes     188,074       251,988  
Accrued professional services     765,948       430,088  
Other     329,523       383,960  
Total accrued liabilities     3,087,328       3,283,942  
Less: Long term accrued liabilities     (813,641 )     (641,461 )
Total current accrued liabilities   $ 2,273,687     $ 2,642,481  

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Long-Term Debt and Credit Facilities
3 Months Ended
Mar. 31, 2019
Debt Disclosure [Abstract]  
Long-Term Debt and Credit Facilities

8. Long-Term Debt and Credit Facilities

 

The Company had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The working capital line of credit matured on April 25, 2019. The revolving line of credit was secured by substantially all of the Company’s assets. The maximum available under the line was $5.0 million subject to the value of collateralized assets and the interest rate was equal to the prime rate subject to a floor of 4.5%. The Company was required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender.

 

As of March 31, 2019, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit were made based on the borrowing capacity one week in arrears. As of March 31, 2019, the Company had a borrowing capacity of $3.3 million based on the Company’s collateralized assets. The Company’s total liquidity as of March 31, 2019, was $12.3 million which included cash and cash equivalents of $9.0 million.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Convertible Preferred Stock and Stockholders' Equity
3 Months Ended
Mar. 31, 2019
Stockholders' Equity Note [Abstract]  
Convertible Preferred Stock and Stockholders' Equity

9. Convertible Preferred Stock and Stockholders’ Equity

 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of March 31, 2019.

 

Convertible Preferred Stock and Warrants

 

In September 2016, the Company issued 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company’s common stock at an initial conversion rate of $0.65 per share and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Each holder of convertible preferred shares has the right to require us to redeem such holder’s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a defined change of control. The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company’s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.

 

The warrants issued in conjunction with the convertible preferred stock (the “SPA Warrants”) have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants were originally puttable upon the occurrence of certain events outside of the Company’s control, and were classified as liabilities under Accounting Standards Codification (“ASC”) Topic 480-10. The calculated fair value of the warrants was periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations.

 

The warrants were modified on February 28, 2018 to allow for a reduction in the exercise price from $0.70 per share to $0.28 per share for a period between March 1, 2018 and March 5, 2018. Any holder who exercised warrants at the reduced strike price was required to enter into a lock-up agreement with the Company agreeing not to sell the warrants or the common shares received upon exercise of the warrants for a period of 18 months following March 12, 2018. Additionally, the beneficial ownership limitation related to the warrants was modified and the right of holders to require the Company to redeem their SPA Warrants in exchange for cash in certain circumstances was eliminated. Following these modifications, the warrants were no longer subject to liability accounting and were reclassified to equity. During the restricted exercise period, Stereotaxis received exercise notices for 35,791,927 warrants and received an aggregate of $10.0 million in cash from the warrant exercise. As a result of these transactions, total stockholders’ equity increased by $27 million and common shares outstanding increased by 35,791,927 shares. The Consent and Amendment and the Amended and Restated Form of Warrants are available in a Form 8-K filed with the Securities and Exchange Commission on March 6, 2018.

 

Stock Award Plans

 

The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.

 

On June 5, 2013, June 10, 2014, May 24, 2016, and May 23, 2017, the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares, and the amendment on May 23, 2017 increased the number of shares authorized for issuance under the Plan by 4.0 million shares. At March 31, 2019, the Company had 3,246,524 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

 

At March 31, 2019, the total compensation cost related to options, stock appreciation rights, and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $2.2 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.

 

A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2019 is as follows:

 

    Number of Options/SARs     Range of Exercise Price     Weighted Average Exercise Price per Share  
                   
Outstanding, December 31, 2018     1,165,086       $0.74 - $43.90     $ 2.54  
Granted     982,000       $2.03     $ 2.03  
Exercised     (9,625 )     $0.74 - $0.83     $ 0.74  
Forfeited     (5,948 )     $0.74 - $4.04     $ 1.59  
Outstanding, March 31, 2019     2,131,513       $0.74 - $43.90     $ 2.32  

 

A summary of the restricted stock unit activity for the three month period ended March 31, 2019 is as follows:

 

    Number of Restricted
Stock Units
    Weighted Average Grant Date Fair Value per Unit  
             
Outstanding, December 31, 2018     647,649     $ 0.83  
Granted     210,000     $ 1.19  
Vested     (166,962 )   $ 1.12  
Forfeited     (2,000 )   $ 0.72  
Outstanding, March 31, 2019     688,687     $ 0.87  

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Product Warranty Provisions
3 Months Ended
Mar. 31, 2019
Product Warranties Disclosures [Abstract]  
Product Warranty Provisions

10. Product Warranty Provisions

 

The Company’s standard policy is to warrant all capital systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

 

Accrued warranty, which is included in other accrued liabilities, consists of the following:

 

    March 31, 2019     December 31, 2018  
Warranty accrual, beginning of the fiscal period   $ 149,464     $ 164,365  
Accrual adjustment for product warranty     17,135       34,253  
Payments made     (29,653 )     (49,154 )
Warranty accrual, end of the fiscal period   $ 136,946     $ 149,464  

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

11. Commitments and Contingencies

 

The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events
3 Months Ended
Mar. 31, 2019
Subsequent Events [Abstract]  
Subsequent Events

12. Subsequent Events

 

None.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.

 

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.

Going Concern, Liquidity and Management's Plan

Going Concern, Liquidity and Management’s Plan

 

The Company believes the cash on hand at March 31, 2019 will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. The Company has sustained operating losses throughout its corporate history and expects that its 2019 expenses will exceed its 2019 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of robotic magnetic navigation systems as well as by new placements of capital systems. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.

Financial Instruments

Financial Instruments

 

Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).

Revenue and Costs of Revenue

Revenue and Costs of Revenue

 

The Company adopted Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from Contracts with Customers, on January 1, 2018.

 

We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented less than 1% of revenue for the three months ended March 31, 2019 and 2018.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 36% and 37% of revenue for the three months ended March 31, 2019 and 2018, respectively.

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 11% and 10% of revenue for the three months ended March 31, 2019 and 2018.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 50% and 53% of revenue for the three months ended March 31, 2019 and 2018, respectively.

 

Sublease Revenue:

 

The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning with three months ended March 31, 2019. Sublease revenue represented 3% and 0% of revenue for the three months ended March 31, 2019 and 2018, respectively.

 

    Three Months Ended March 31,  
    2019     2018  
Systems   $ 58,051     $ 17,275  
Disposables, service and accessories     6,710,759       6,954,357  
Sublease     241,065        
Total revenue   $ 7,009,875     $ 6,971,632  

 

Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $2.7 million as of March 31, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.

 

The following information summarizes the Company’s contract assets and liabilities:

 

    March 31, 2019     December 31, 2018  
Contract Assets - Unbilled Receivables   $ 268,711     $ 251,867  
                 
Customer deposits     428,595       487,086  
Product shipped, revenue deferred     645,199       645,199  
Deferred service and license fees     4,976,628       5,100,402  
Total deferred revenue     6,050,422       6,232,687  
Less: Long-term deferred revenue     (404,607 )     (407,151 )
Total current deferred revenue   $ 5,645,815     $ 5,825,536  

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Revenue recognized for the three months ended March 31, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $2.9 million and $2.7 million respectively.

Assets Recognized from the Costs to Obtain a Contract with a Customer

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $0.3 million as of March 31, 2019. The Company did not incur any impairment losses during any of the periods presented.

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

Share-Based Compensation

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

Net Income (Loss) Per Common Share ("EPS")

Net Income (Loss) per Common Share (“EPS”)

 

Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

 

The following table sets forth the computation of basic and diluted EPS:

 

    Three months ended March 31,  
    2019     2018  
Net income (loss)   $ (2,122,820 )   $ 1,435,229  
Cumulative dividend on convertible preferred stock     (353,510 )     (353,589 )
Net loss attributable to convertible preferred stock           (610,280 )
Net income (loss) attributable to common stockholders   $ (2,476,330 )   $ 471,360  
                 
Share used for basic EPS-weighted average shares     59,196,652       30,957,648  
Restricted Stock Units           292,891  
Warrants           1,872,059  
Weighted average number of common shares and equivalents:     59,196,652       33,122,598  
Basic EPS   $ (0.04 )   $ 0.02  
Diluted EPS   $ (0.04 )   $ 0.01  

 

The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common share for the three months ended March 31, 2019 because all such securities are anti-dilutive. The following potential common shares were excluded from diluted EPS for the three months ended March 31, 2018 as they were antidilutive: 1,236,445 stock options and stock appreciation rights, 280,560 restricted stock units, and 1,077,255 warrants. The Company had no unearned restricted shares during either period.

 

As of March 31, 2019, the Company had 2,131,513 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.32 per share, 1,107,689 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 42,252,248 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock and accumulated dividends, and 688,687 shares of unvested restricted share units.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (“ASC 842”) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity’s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease Revenue and the related cost as Sublease Cost of Goods Sold. See Note 6 for additional details.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Schedule of Revenue Disaggregated by Type

    Three Months Ended March 31,  
    2019     2018  
Systems   $ 58,051     $ 17,275  
Disposables, service and accessories     6,710,759       6,954,357  
Sublease     241,065        
Total revenue   $ 7,009,875     $ 6,971,632  

Summary of Contract Assets and Liabilities

The following information summarizes the Company’s contract assets and liabilities:

 

    March 31, 2019     December 31, 2018  
Contract Assets - Unbilled Receivables   $ 268,711     $ 251,867  
                 
Customer deposits     428,595       487,086  
Product shipped, revenue deferred     645,199       645,199  
Deferred service and license fees     4,976,628       5,100,402  
Total deferred revenue     6,050,422       6,232,687  
Less: Long-term deferred revenue     (404,607 )     (407,151 )
Total current deferred revenue   $ 5,645,815     $ 5,825,536  

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted EPS:

 

    Three months ended March 31,  
    2019     2018  
Net income (loss)   $ (2,122,820 )   $ 1,435,229  
Cumulative dividend on convertible preferred stock     (353,510 )     (353,589 )
Net loss attributable to convertible preferred stock           (610,280 )
Net income (loss) attributable to common stockholders   $ (2,476,330 )   $ 471,360  
                 
Share used for basic EPS-weighted average shares     59,196,652       30,957,648  
Restricted Stock Units           292,891  
Warrants           1,872,059  
Weighted average number of common shares and equivalents:     59,196,652       33,122,598  
Basic EPS   $ (0.04 )   $ 0.02  
Diluted EPS   $ (0.04 )   $ 0.01  

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Inventories (Tables)
3 Months Ended
Mar. 31, 2019
Inventory Disclosure [Abstract]  
Schedule of Inventories

Inventories consist of the following:

 

    March 31, 2019     December 31, 2018  
             
Raw materials   $ 2,657,958     $ 2,686,870  
Work in process     133,218       2,594  
Finished goods     2,944,522       2,963,013  
Reserve for obsolescence     (4,426,564 )     (4,460,811 )
Total inventory   $ 1,309,134     $ 1,191,666  

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Prepaid Expenses and Other Assets (Tables)
3 Months Ended
Mar. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Prepaid Expenses and Other Assets

Prepaid expenses and other assets consist of the following:

 

    March 31, 2019     December 31, 2018  
             
Prepaid expenses   $ 434,560     $ 401,972  
Prepaid commissions     271,664       304,585  
Deposits     237,878       455,508  
Total prepaid expenses and other assets     944,102       1,162,065  
Less: Noncurrent prepaid expenses and other assets     (170,088 )     (198,365 )
Total current prepaid expenses and other assets   $ 774,014     $ 963,700  

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Property and Equipment (Tables)
3 Months Ended
Mar. 31, 2019
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment consist of the following:

 

    March 31, 2019     December 31, 2018  
             
Equipment   $ 6,841,498     $ 6,831,665  
Leasehold improvements     2,592,339       2,592,339  
      9,433,837       9,424,004  
Less: Accumulated depreciation     (9,105,223 )     (9,080,311 )
Net property and equipment   $ 328,614     $ 343,693  

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Leases (Tables)
3 Months Ended
Mar. 31, 2019
Leases [Abstract]  
Schedule of Lease Costs and Other Lease Information

The following table represents lease costs and other lease information.

 

    Three Months Ended  
    March 31, 2019  
       
Operating lease cost   $ 585,586  
Short-term lease cost     19,809  
Sublease income     (241,065 )
Total lease cost   $ 364,330  
         
Cash paid within operating cash flows   $ 615,266  

Schedule of Future Minimum Operating Lease Payments

Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2019, excluding sublease income, were as follows:

 

    March 31, 2019  
       
2019   $ 1,717,837  
2020     2,339,810  
2021     2,382,661  
2022 and thereafter     -  
Total lease payments   $ 6,440,308  
Less: Interest     (846,934 )
Present value of lease liabilities   $ 5,593,374  

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Accrued Liabilities (Tables)
3 Months Ended
Mar. 31, 2019
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities

Accrued liabilities consist of the following:

 

    March 31, 2019     December 31, 2018  
             
Accrued salaries, bonus, and benefits   $ 1,182,958     $ 1,491,844  
Accrued licenses and maintenance fees     483,879       576,598  
Accrued warranties     136,946       149,464  
Accrued taxes     188,074       251,988  
Accrued professional services     765,948       430,088  
Other     329,523       383,960  
Total accrued liabilities     3,087,328       3,283,942  
Less: Long term accrued liabilities     (813,641 )     (641,461 )
Total current accrued liabilities   $ 2,273,687     $ 2,642,481  

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Convertible Preferred Stock and Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2019
Stockholders' Equity Note [Abstract]  
Summary of Option and Stock Appreciation Rights Activity

A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2019 is as follows:

 

    Number of Options/SARs     Range of Exercise Price     Weighted Average Exercise Price per Share  
                   
Outstanding, December 31, 2018     1,165,086       $0.74 - $43.90     $ 2.54  
Granted     982,000       $2.03     $ 2.03  
Exercised     (9,625 )     $0.74 - $0.83     $ 0.74  
Forfeited     (5,948 )     $0.74 - $4.04     $ 1.59  
Outstanding, March 31, 2019     2,131,513       $0.74 - $43.90     $ 2.32  

Summary of Restricted Stock Unit Activity

A summary of the restricted stock unit activity for the three month period ended March 31, 2019 is as follows:

 

    Number of Restricted
Stock Units
    Weighted Average Grant Date Fair Value per Unit  
             
Outstanding, December 31, 2018     647,649     $ 0.83  
Granted     210,000     $ 1.19  
Vested     (166,962 )   $ 1.12  
Forfeited     (2,000 )   $ 0.72  
Outstanding, March 31, 2019     688,687     $ 0.87  

XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Product Warranty Provisions (Tables)
3 Months Ended
Mar. 31, 2019
Product Warranties Disclosures [Abstract]  
Schedule of Accrued Warranty

Accrued warranty, which is included in other accrued liabilities, consists of the following:

 

    March 31, 2019     December 31, 2018  
Warranty accrual, beginning of the fiscal period   $ 149,464     $ 164,365  
Accrual adjustment for product warranty     17,135       34,253  
Payments made     (29,653 )     (49,154 )
Warranty accrual, end of the fiscal period   $ 136,946     $ 149,464  

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Description of Business (Details Narrative)
Mar. 31, 2019
Integer
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Installed base 126
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Remaining performance obligation $ 2,700,000    
Revenue recognized 2,900,000 $ 2,700,000  
Capitalized contract acquisition costs $ 300,000    
Share-based compensation, requisite service period 4 years    
Options and stock appreciation rights 2,131,513   1,165,086
Weighted average exercise price $ 2.32   $ 2.54
Exercise price of warrants $ 0.70    
Series A Convertible Preferred Stock [Member]      
Options and stock appreciation rights 42,252,248    
Warrant [Member]      
Common stock issuable upon exercise, warrants 1,107,689    
Exercise price of warrants $ 0.70    
Stock Options and Stock Appreciation Rights [Member]      
Options and stock appreciation rights 2,131,513    
Weighted average exercise price $ 2.32    
Restricted Stock Units [Member]      
Unvested restricted shares 688,687   647,649
Stock Options and Stock Appreciation Rights [Member]      
Potential common shares excluded from diluted earning per share   1,236,445  
Restricted Stock Units [Member]      
Potential common shares excluded from diluted earning per share   280,560  
Warrant [Member]      
Potential common shares excluded from diluted earning per share   1,077,255  
Revenue from System Delivery and Installation [Member]      
Revenues percentage 1.00% 1.00%  
Disposable Revenue [Member]      
Revenues percentage 36.00% 37.00%  
Royalty Revenue [Member]      
Revenues percentage 11.00% 10.00%  
Other Recurring Revenue [Member]      
Revenues percentage 50.00% 53.00%  
Sublease Revenue [Member]      
Revenues percentage 3.00% 0.00%  
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Type (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Total revenue $ 7,009,875 $ 6,971,632
Sublease 241,065
Systems [Member]    
Total revenue 58,051 17,275
Disposables, Service and Accessories [Member]    
Total revenue $ 6,710,759 $ 6,954,357
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Total deferred revenue $ 6,050,422 $ 6,232,687
Less: Long-term deferred revenue (404,607) (407,151)
Total current deferred revenue 5,645,815 5,825,536
Contract Assets - Unbilled Receivables [Member]    
Total deferred revenue 268,711 251,867
Customer Deposits [Member]    
Total deferred revenue 428,595 487,086
Product Shipped, Revenue Deferred [Member]    
Total deferred revenue 645,199 645,199
Deferred Service and License Fees [Member]    
Total deferred revenue $ 4,976,628 $ 5,100,402
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Accounting Policies [Abstract]    
Net income (loss) $ (2,122,820) $ 1,435,229
Cumulative dividend on convertible preferred stock (353,510) (353,589)
Net loss attributable to convertible preferred stock 610,280
Net income (loss) attributable to common stockholders $ (2,476,330) $ 471,360
Share used for basic EPS-weighted average shares 59,196,652 30,957,648
Restricted Stock Units 292,891
Warrants 1,872,059
Weighted average number of common shares and equivalents: 59,196,652 33,122,598
Basic EPS $ (0.04) $ 0.02
Diluted EPS $ (0.04) $ 0.01
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Inventories - Schedule of Inventories (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Inventory Disclosure [Abstract]    
Raw materials $ 2,657,958 $ 2,686,870
Work in process 133,218 2,594
Finished goods 2,944,522 2,963,013
Reserve for obsolescence (4,426,564) (4,460,811)
Total inventory $ 1,309,134 $ 1,191,666
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.1
Prepaid Expenses and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid expenses $ 434,560 $ 401,972
Prepaid commissions 271,664 304,585
Deposits 237,878 455,508
Total prepaid expenses and other assets 944,102 1,162,065
Less: Noncurrent prepaid expenses and other assets (170,088) (198,365)
Total current prepaid expenses and other assets $ 774,014 $ 963,700
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Gross property and equipment $ 9,433,837 $ 9,424,004
Less: Accumulated depreciation (9,105,223) (9,080,311)
Net property and equipment 328,614 343,693
Equipment [Member]    
Gross property and equipment 6,841,498 6,831,665
Leasehold Improvements [Member]    
Gross property and equipment $ 2,592,339 $ 2,592,339
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.19.1
Leases (Details Narrative) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Leases [Abstract]    
Weighted average discount rate for operating leases 9.00%  
Weighted average remaining lease term for operating lease term 2 years 9 months  
Right of use assets $ 5,580,457
Undiscounted future cash flows to be received under the sublease 2019 700,000  
undiscounted future cash flows to be received under the sublease 2020 1,000,000  
undiscounted future cash flows to be received under the sublease 2021 $ 1,000,000  
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Schedule of Lease Costs and Other Lease Information (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Leases [Abstract]    
Operating lease cost $ 585,586  
Short-term lease cost 19,809  
Sublease income (241,065)
Total lease cost 364,330  
Cash paid within operating cash flows $ 615,266  
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Leases - Schedule of Future Minimum Operating Lease Payments (Details)
Mar. 31, 2019
USD ($)
Leases [Abstract]  
2019 $ 1,717,837
2020 2,339,810
2021 2,382,661
2022 and thereafter
Total lease payments 6,440,308
Less: Interest (846,934)
Present value of lease liabilities $ 5,593,374
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Payables and Accruals [Abstract]      
Accrued salaries, bonus, and benefits $ 1,182,958 $ 1,491,844  
Accrued licenses and maintenance fees 483,879 576,598  
Accrued warranties 136,946 149,464 $ 164,365
Accrued taxes 188,074 251,988  
Accrued professional services 765,948 430,088  
Other 329,523 383,960  
Total accrued liabilities 3,087,328 3,283,942  
Less: Long term accrued liabilities (813,641) (641,461)  
Total current accrued liabilities $ 2,273,687 $ 2,642,481  
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Long-Term Debt and Credit Facilities (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Debt Instrument [Line Items]    
Total liquidity $ 12,300,000  
Cash and cash equivalents 9,040,816 $ 10,796,072
Revolving Credit Facility [Member]    
Debt Instrument [Line Items]    
Line of credit facility, maximum borrowing capacity  
Line of credit facility, current borrowing capacity 3,300,000  
Revolving Credit Facility [Member] | Primary Lender [Member]    
Debt Instrument [Line Items]    
Line of credit facility, maximum borrowing capacity $ 5,000,000  
Revolving Credit Facility [Member] | Prime Rate [Member] | Primary Lender [Member]    
Debt Instrument [Line Items]    
Line of credit maturity date Apr. 25, 2019  
Line of credit interest rate 4.50%  
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Convertible Preferred Stock and Stockholders' Equity (Details Narrative)
1 Months Ended 3 Months Ended
Mar. 05, 2018
USD ($)
$ / shares
shares
May 23, 2017
shares
May 24, 2016
shares
Jun. 10, 2014
shares
Jun. 05, 2013
shares
Sep. 30, 2016
$ / shares
shares
Mar. 31, 2019
USD ($)
Integer
$ / shares
shares
Mar. 31, 2018
USD ($)
Dec. 31, 2018
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of stockholders votes | Integer             1    
Dividends declared | $                
Dividends paid | $                
Preferred stock, stated value             $ 0.001   $ 0.001
Exercise price of warrants             $ 0.70    
Warrants exercisable date             Sep. 29, 2021    
Proceeds from warrant exercise | $             $ 9,945,164  
Increased in stockholders' equity | $ $ 27,000,000                
Increased in common shares outstanding | shares 35,791,927                
Remaining shares available for issuance | shares             3,246,524    
Total compensation cost not yet recognized | $             $ 2,200,000    
Weighted average amortization period of total compensation cost not yet recognized             4 years    
2012 Stock Incentive Plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Increase in number of shares authorized for issuance under the plan | shares   4,000,000 1,500,000 1,000,000 1,000,000        
Warrant [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Exercise price of warrants             $ 0.70    
Number of restricted warrants exercise | shares 35,791,927                
Proceeds from warrant exercise | $ $ 10,000,000                
Maximum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Exercise price of warrants $ 0.70                
Minimum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Exercise price of warrants $ 0.28                
Series A Convertible Preferred Stock [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of preferred stock issued | shares           24,000      
Preferred stock, par value           $ 0.001      
Preferred stock, stated value           1,000      
Preferred stock, conversion price           $ 0.65      
Common stock issuable from warrants | shares           36,923,078      
Preferred stock dividend rate           6.00%      
Preferred stock redemption, triggering event, percent of common stock sold threshold           50.00%      
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.19.1
Convertible Preferred Stock and Stockholders' Equity - Summary of Option and Stock Appreciation Rights Activity (Details)
3 Months Ended
Mar. 31, 2019
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options/SARs, Outstanding, Beginning Balance | shares 1,165,086
Number of Options/SARs, Granted | shares 982,000
Number of Options/SARs, Exercised | shares (9,625)
Number of Options/SARs, Forfeited | shares (5,948)
Number of Options/SARs, Outstanding, Ending Balance | shares 2,131,513
Weighted Average Exercise Price per Share, Outstanding, Beginning Balance $ 2.54
Weighted Average Exercise Price per Share, Granted 2.03
Weighted Average Exercise Price per Share, Exercised 0.74
Weighted Average Exercise Price per Share, Forfeited 1.59
Weighted Average Exercise Price per Share, Outstanding, Ending Balance 2.32
Range One [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Lower Limit 0.74
Range of Exercise Price, Upper Limit 43.90
Range Two [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Upper Limit 2.03
Range Three [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Lower Limit 0.74
Range of Exercise Price, Upper Limit 0.83
Range Four [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Lower Limit 0.74
Range of Exercise Price, Upper Limit 4.04
Range Five [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Lower Limit 0.74
Range of Exercise Price, Upper Limit $ 43.90
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.19.1
Convertible Preferred Stock and Stockholders' Equity - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units [Member]
3 Months Ended
Mar. 31, 2019
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Restricted Stock Units, Outstanding, December 31, 2018 | shares 647,649
Number of Restricted Stock Units, Granted | shares 210,000
Number of Restricted Stock Units, Vested | shares (166,962)
Number of Restricted Stock Units, Forfeited | shares (2,000)
Number of Restricted Stock Units, Outstanding, March 31, 2019 | shares 688,687
Weighted Average Grant Date Fair Value per Unit, Outstanding, December 31, 2018 | $ / shares $ 0.83
Weighted Average Grant Date Fair Value per Unit, Granted | $ / shares 1.19
Weighted Average Grant Date Fair Value per Unit, Vested | $ / shares 1.12
Weighted Average Grant Date Fair Value per Unit, Forfeited | $ / shares 0.72
Weighted Average Grant Date Fair Value per Unit, Outstanding, March 31, 2019 | $ / shares $ 0.87
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.19.1
Product Warranty Provisions (Details Narrative)
3 Months Ended
Mar. 31, 2019
Product Warranties Disclosures [Abstract]  
Standard product warranty coverage term 1 year
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.19.1
Product Warranty Provisions - Schedule of Accrued Warranty (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Product Warranties Disclosures [Abstract]    
Warranty accrual, beginning of the fiscal period $ 149,464 $ 164,365
Accrual adjustment for product warranty 17,135 34,253
Payments made (29,653) (49,154)
Warranty accrual, end of the fiscal period $ 136,946 $ 149,464
EXCEL 57 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 59 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 91 222 1 true 37 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://stereotaxis.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets Sheet http://stereotaxis.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Parenthetical) Sheet http://stereotaxis.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations (Unaudited) Sheet http://stereotaxis.com/role/StatementsOfOperations Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) Sheet http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Statements of Cash Flows (Unaudited) Sheet http://stereotaxis.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Description of Business Sheet http://stereotaxis.com/role/DescriptionOfBusiness Description of Business Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Inventories Sheet http://stereotaxis.com/role/Inventories Inventories Notes 9 false false R10.htm 00000010 - Disclosure - Prepaid Expenses and Other Assets Sheet http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets Prepaid Expenses and Other Assets Notes 10 false false R11.htm 00000011 - Disclosure - Property and Equipment Sheet http://stereotaxis.com/role/PropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 00000012 - Disclosure - Leases Sheet http://stereotaxis.com/role/Leases Leases Notes 12 false false R13.htm 00000013 - Disclosure - Accrued Liabilities Sheet http://stereotaxis.com/role/AccruedLiabilities Accrued Liabilities Notes 13 false false R14.htm 00000014 - Disclosure - Long-Term Debt and Credit Facilities Sheet http://stereotaxis.com/role/Long-termDebtAndCreditFacilities Long-Term Debt and Credit Facilities Notes 14 false false R15.htm 00000015 - Disclosure - Convertible Preferred Stock and Stockholders' Equity Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity Convertible Preferred Stock and Stockholders' Equity Notes 15 false false R16.htm 00000016 - Disclosure - Product Warranty Provisions Sheet http://stereotaxis.com/role/ProductWarrantyProvisions Product Warranty Provisions Notes 16 false false R17.htm 00000017 - Disclosure - Commitments and Contingencies Sheet http://stereotaxis.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 00000018 - Disclosure - Subsequent Events Sheet http://stereotaxis.com/role/SubsequentEvents Subsequent Events Notes 18 false false R19.htm 00000019 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Inventories (Tables) Sheet http://stereotaxis.com/role/InventoriesTables Inventories (Tables) Tables http://stereotaxis.com/role/Inventories 21 false false R22.htm 00000022 - Disclosure - Prepaid Expenses and Other Assets (Tables) Sheet http://stereotaxis.com/role/PrepaidExpensesAndOtherAssetsTables Prepaid Expenses and Other Assets (Tables) Tables http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets 22 false false R23.htm 00000023 - Disclosure - Property and Equipment (Tables) Sheet http://stereotaxis.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://stereotaxis.com/role/PropertyAndEquipment 23 false false R24.htm 00000024 - Disclosure - Leases (Tables) Sheet http://stereotaxis.com/role/LeasesTables Leases (Tables) Tables http://stereotaxis.com/role/Leases 24 false false R25.htm 00000025 - Disclosure - Accrued Liabilities (Tables) Sheet http://stereotaxis.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://stereotaxis.com/role/AccruedLiabilities 25 false false R26.htm 00000026 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Tables) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables Convertible Preferred Stock and Stockholders' Equity (Tables) Tables http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity 26 false false R27.htm 00000027 - Disclosure - Product Warranty Provisions (Tables) Sheet http://stereotaxis.com/role/ProductWarrantyProvisionsTables Product Warranty Provisions (Tables) Tables http://stereotaxis.com/role/ProductWarrantyProvisions 27 false false R28.htm 00000028 - Disclosure - Description of Business (Details Narrative) Sheet http://stereotaxis.com/role/DescriptionOfBusinessDetailsNarrative Description of Business (Details Narrative) Details http://stereotaxis.com/role/DescriptionOfBusiness 28 false false R29.htm 00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables 29 false false R30.htm 00000030 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Type (Details) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfRevenueDisaggregatedByTypeDetails Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Type (Details) Details 30 false false R31.htm 00000031 - Disclosure - Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfContractAssetsAndLiabilitiesDetails Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) Details 31 false false R32.htm 00000032 - Disclosure - Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies-ComputationOfBasicAndDilutedEarningsPerShareDetails Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) Details 32 false false R33.htm 00000033 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://stereotaxis.com/role/Inventories-ScheduleOfInventoriesDetails Inventories - Schedule of Inventories (Details) Details 33 false false R34.htm 00000034 - Disclosure - Prepaid Expenses and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) Sheet http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets-ScheduleOfPrepaidExpensesAndOtherAssetsDetails Prepaid Expenses and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) Details 34 false false R35.htm 00000035 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://stereotaxis.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails Property and Equipment - Schedule of Property and Equipment (Details) Details 35 false false R36.htm 00000036 - Disclosure - Leases (Details Narrative) Sheet http://stereotaxis.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://stereotaxis.com/role/LeasesTables 36 false false R37.htm 00000037 - Disclosure - Leases - Schedule of Lease Costs and Other Lease Information (Details) Sheet http://stereotaxis.com/role/Leases-ScheduleOfLeaseCostsAndOtherLeaseInformationDetails Leases - Schedule of Lease Costs and Other Lease Information (Details) Details 37 false false R38.htm 00000038 - Disclosure - Leases - Schedule of Future Minimum Operating Lease Payments (Details) Sheet http://stereotaxis.com/role/Leases-ScheduleOfFutureMinimumOperatingLeasePaymentsDetails Leases - Schedule of Future Minimum Operating Lease Payments (Details) Details 38 false false R39.htm 00000039 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details) Sheet http://stereotaxis.com/role/AccruedLiabilities-ScheduleOfAccruedLiabilitiesDetails Accrued Liabilities - Schedule of Accrued Liabilities (Details) Details 39 false false R40.htm 00000040 - Disclosure - Long-Term Debt and Credit Facilities (Details Narrative) Sheet http://stereotaxis.com/role/Long-termDebtAndCreditFacilitiesDetailsNarrative Long-Term Debt and Credit Facilities (Details Narrative) Details http://stereotaxis.com/role/Long-termDebtAndCreditFacilities 40 false false R41.htm 00000041 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Details Narrative) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative Convertible Preferred Stock and Stockholders' Equity (Details Narrative) Details http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables 41 false false R42.htm 00000042 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Summary of Option and Stock Appreciation Rights Activity (Details) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity-SummaryOfOptionAndStockAppreciationRightsActivityDetails Convertible Preferred Stock and Stockholders' Equity - Summary of Option and Stock Appreciation Rights Activity (Details) Details 42 false false R43.htm 00000043 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Summary of Restricted Stock Unit Activity (Details) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity-SummaryOfRestrictedStockUnitActivityDetails Convertible Preferred Stock and Stockholders' Equity - Summary of Restricted Stock Unit Activity (Details) Details 43 false false R44.htm 00000044 - Disclosure - Product Warranty Provisions (Details Narrative) Sheet http://stereotaxis.com/role/ProductWarrantyProvisionsDetailsNarrative Product Warranty Provisions (Details Narrative) Details http://stereotaxis.com/role/ProductWarrantyProvisionsTables 44 false false R45.htm 00000045 - Disclosure - Product Warranty Provisions - Schedule of Accrued Warranty (Details) Sheet http://stereotaxis.com/role/ProductWarrantyProvisions-ScheduleOfAccruedWarrantyDetails Product Warranty Provisions - Schedule of Accrued Warranty (Details) Details 45 false false All Reports Book All Reports stxs-20190331.xml stxs-20190331.xsd stxs-20190331_cal.xml stxs-20190331_def.xml stxs-20190331_lab.xml stxs-20190331_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2019-01-31 true true ZIP 62 0001493152-19-006640-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-19-006640-xbrl.zip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